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Nanoparticle-based technology has reached a threshold where biocompatible NPs with controllable 
size, morphologies, and functionality are becoming widely fabricated and utilized. This dissertation 
evaluates new nanobiophotonic platforms for nanotherapy and nanoimaging applications, including 
polyacrylamide (PAAm)-encapsulated metal clusters, plasmonic nanosnakes, and RGD-targeted 
fluorescent 8-arm-peg NPs.  
 We first examine biocompatible polyacrylamide (PAAm)-encapsulated Au25Capt18 metal 
nanoclusters (NCs) for applications in two-photon photodynamic therapy. We demonstrate highly 
efficacious in vitro two-photon PDT for these PAAm-Au25Capt18 NPs, exhibiting a tremendous 
enhancement in 2p-PDT-mediated cell death over one-photon PDT-mediated cell death. Furthermore, 
we show that as a new two-photon photodynamic agent, the Au25Capt18cluster, (a) has a two-photon 
cross-section 8x larger when compared to 5,10,15,20-Tetrakis(1-methyl-4-pyridinio)porphyrin tetra(p-
toluenesulfonate) (TMPYP), the currently most used two-photon photosensitizer, (b) has modest 
reactive oxygen species (ROS) production (1%) under two-photon excitation, with the potential for this 
efficiency to be further improved, and (c) when embedded in hydrogel NPs it maintains its unique 
optical properties while achieving 100% higher tumor uptake and biocompatibility. 
Next, we fabricate and characterize highly linear plasmonic nanochains of gold nanospheres, which 
we call “nanosnakes”. These nanosnakes are self-assembled from bare Au nanosphere monomers with 
virgin surfaces, produced in DI water by laser ablation (a green, chemical-free synthesis). The 
nanosnakes have several highly desirable properties for biological imaging, including two plasmonic 





tunable mode ranges from 590 nm to 640 nm, with tunability precision within 1-2 nm. Such tunability 
towards the infrared is a highly desirable property in plasmonic imaging, due to these photons’ deeper 
tissue penetration as well as due to their much reduced background cell fluorescence. We also show 
that the nanosnakes possess scattering cross-sections up to 40x higher than the Au nanosphere 
monomers (approximately 3x higher per chain monomer nanosphere), thus making them better 
contrast agents for imaging applications. Lastly, we demonstrate that the nanosnakes can be easily 
conjugated with active targeting moieties, for applications such as targeted cancer and heart disease 
phototherapy, using the RGD peptide as a model system; furthermore, we show that they are also non-
toxic to cells, even at very high concentrations (> 0.25 mg/mL, OD 5.0). Overall, the nanosnakes 
represent a promising new imaging modality for dark-field, SERS, and high resolution microscopy, and 
have a high potential for in vivo theranostic applications. 
Lastly, we evaluate fluorescent 8-arm-peg NPs for their RGD-assisted targeting to the age-related 
macular degeneration (AMD) neovasculature. In vitro experiments reveal a strong, measurable difference 
between non-targeted and RGD targeted NPs, with the RGD targeted NPs showing nearly a 100 % increase 
in cellular uptake at the highest incubated NP concentration (3 mg/mL). In vivo experiments at high 
incubated PEG-RGD concentrations (20 mg/mL injections) show approximately 15-20% enhancement in 
targeting signal, when compared to non-RGD controls. Overall, we show that 8-arm PEG NPs are a new, 
readily conjugatable and targetable nanosystem for future optimized AMD diagnosis and therapy, with 
potential benefits for in vivo theranostic enhancement. 
Overall, this dissertation evaluates polyacrylamide (PAAm)-encapsulated metal clusters, 
plasmonic nanosnakes, and RGD-targeted fluorescent 8-arm-peg NPs. These nanobiophotonic platforms 
are biocompatible, deliverable in vitro and/or in vivo, and exhibit specialized utility, with clear advantages 
as a new nanomaterial in cancer therapy, plasmonic imaging, and/or disease targeting for applied 





Chapter 1: Introduction 
 The focus of this dissertation is on applied nanotechnology for biomedical applications. The field 
of nanotechnology is one of the most active fields of modern research and is rapidly transforming the 
fields of biology and medicine.  To exemplify the growth of “nanomedicine”, the number of FDA approved 
nanodevices has been growing exponentially since 2000, with many new drugs in development.1 This 
introduction will introduce the core concepts from each chapter of the thesis. In section 1.1, nanoparticles 
are defined and their basic properties are discussed in relation to applied biomedicine. In section 1.2, 
nanoparticle-based photodynamic therapy (PDT), a medical treatment involving targeted light therapy, is 
introduced. In section 1.3, an introduction to nanoparticle-based dark-field imaging is presented, with 
core concepts of theoretical modeling also outlined. In section 1.4, nanoparticle-based active targeting is 
discussed, and applications towards macular degeneration (MD)-targeting are introduced. Lastly, section 
1.5 presents an outline for the remainder of the dissertation.  
1.1 An Introduction to Nanoparticles 
1.1.1 What is a Nanoparticle? 
The standard definition of a nanomaterial is any material on the scale of 1 – 1000 nm in at least one 
dimension.2 Nanomaterials are ubiquitous throughout nature; for example, viruses are largely on the scale 
of nanometers.3 Furthermore, as an important historical example, interplanetary dust has naturally 
occurring morphologies on the nanometer scale, an example which is provided in Figure 1.1; this lead to 
the development of computational methods to study nanoparticle physics (i.e. Mie Theory and Discrete 
Dipole Scattering Theory, utilized extensively in Chapter 3).4 Originating with mankind, nanomaterials 





(Au) and silver (Ag) have been used in stained glass for centuries, which gives the glass their characteristic 
hues, as shown in Figure 1.1.  
Figure 1.1 (Left) Interplanetary dust particle, thought to originate from a comet. The particle measures 18 
µm in its longest axis, with nano-sized sub-morphologies. (Right) Stained glass window in the University 
Library at Cornell. Starting from around the 10th century, silver and gold nanoparticles were used to give 
stained glass yellow and red hue, albeit their nature as nanomaterials was unknown until the 20th century. 
However, until half a century ago, the field of nanoscience remained practically unstudied.6 The 
systematic study of nanoparticles began in the 1970s-1980s, with the coinage of the term nanotechnology 
in 1974.6 To achieve some of the first lab-made nanoparticles, the fabrication of nanoparticles had often 
consisted of using a mortar and pestle to grind materials down into a sub-µm grain.7 However, in modern 
days, the fabrication, variability, and even the definition of a nanoparticle has evolved.  
1.1.2 Nanoparticle Size and Enhanced Permeability and Retention (EPR) 
For biological applications in the modern day, nanoparticles under 250 nm are generally utilized, and 
the size of the nanoparticle is one of the major parameters of biological importance. For example, larger 
nanoparticles (250+ nm) are typically too large to be efficiently uptaken by cells.8,9 In addition, 





which means that nanoparticles accumulate passively, and in higher concentrations, in specific tissue 
types (like cancer tissue) more than in normal tissue.10 Due to the EPR Effect, nanoparticles are a very 
attractive modality for specific medical applications, like that of cancer medicine. In addition to “passive” 
accumulation (EPR), nanoparticles can be “actively targeted”, being conjugated with small molecules, 
peptides, or antibodies for targeting to specific tissues or cells.11,12 For example, the RGD peptide 
(RGDRGDRGDRGDPGC) is an example of a peptide moiety that binds to Integrin receptors, which are 
upregulated in cancer cells.13 In conjunction with the EPR effect, this synergy creates a great enhancement 
of nanoparticle uptake for a targeted region of interest, like cancer tumor tissue (see Zhan, et. al., for 
example).14 A more detailed discussion of active targeting is provided in section 1.4.1 of the introduction, 
as developing active targeting moieties for the treatment of macular degeneration has been a major 
research focus for the Kopelman laboratory. 
1.1.3  The Variability of Nanoparticles from 1-200 nm, Nanohydrogels, Peg-based Nanomaterials, and 
Nanometals 
Within the 200 nm framework, many different types of nanoparticles have been developed. As a 
noncomprehensive list, liposomes and micelles, dendrimers, metals (including quantum dots), shell-based 
nanoparticles (i.e. hydrogels), and fullerenes are examples of nanoparticle platforms in use.2,5,15 Each of 
these nanoplatforms has advantages and disadvantages for biological application. For example, liposomes 
and micelles are often highly biocompatible, but also highly sensitive to in vivo degradation.16 In contrast, 
metal-based nanoparticles are often very stable and possess desirable optical properties, but are less 
biocompatible.17,18 Figure 1.2, adapted from Silva et. al,19 pictorially classifies various nanoparticle types 






Figure 1.2 Commonly studied nanoparticle varieties. Overall, nanoparticles are divided into organic 
(dendrimer, biopolymer, liposome, etc.), inorganic (nanotubes, mesoporous silica, gold, iron oxide, 
quantum dot), or hybrid (hydrogel) categories. It is important to note that carbon nanotubes, fullerenes, 
and graphene, while carbon-based, are not traditionally considered an ‘organic’ nanoparticle, as they are 
allotropes of natural carbon. 
Within the scope of this thesis, we investigate three types of nanoparticle platforms: 1.) 
Nanohydrogels (Chapter 2, polymeric acrylamide nanoshell), 2.) Nanometals (Chapters 2 and 3, Au 
nanoclusters20 and nanochains), and 3.) Peg-based nanoplatforms (Chapter 4, 10k and 40k 8-arm-peg). 
Polymeric acrylamide nanohydrogels are highly biocompatible, customizable (size range can be 
synthesized from 20 – 100 nm with low standard deviation), low cost, and easy-to-conjugate shell-based 
nanoplatforms.21–24 Also, due to their shell-like nature, nanohydrogels can encapsulate drugs and optical 





size (5 – 10 nm) than polymeric acrylamide nanohydrogels.25,26 To emphasize the contrast between a 
nanoplatform with targeting and without targeting moieties, using a smaller nanoplatform like 8-arm-peg 
is preferable over larger nanoparticle, as the EPR effect is smaller.  Lastly, Au nanoclusters and nanochains 
are highly useful nanomaterials due to their desirable optical properties. In brief, Au nanoclusters are an 
ultrasmall (1 nm), highly stable, two-photon absorbing (750 – 1000 nm) nanomaterial that produces 
reactive oxygen species (ROS) upon excitation. These “molecular” nanometals can be utilized to elicit cell 
death in select biological regions with the aid of excitation by light. We have also developed Au nanochains 
made of 20 nm Au monomer nanoparticles, which have a tunable (590 – 700 nm) imaging window with 
sub-nm resolution, a highly desirable property in biological imaging. 
1.2 Nanoparticle-based Photodynamic Therapy 
1.2.1 What is Photodynamic Therapy? What Determines a “Good” Photosensitizer? 
Photodynamic therapy (PDT) describes any therapy that utilizes light to excite a chemical 
substance, formally defined as a photosensitizer, leading to the production of reactive oxygen species 
(ROS).27–29 Because reactive oxygen species (ROS) are cytotoxic chemical species even at very low 
concentrations, the production of these reactive oxygen species leads to the killing of nearby cells very 
shortly after they are produced. The history of light therapy dates at least as far back as the use of the 
first nanoparticles: Herodotus, the famous physician of the 2nd century BC, was a proponent of 
heliotherapy, defined as the utilization of the radiation of the sun for therapeutic application.30 In 
addition, the cultures of ancient Egypt, China, and India utilized light to treat diseases such as rickets, 
vitiligo, psoriasis, skin cancer, and psychosis.30 The first modern application of phototherapy dates to the 
late 18th century where photodynamic therapy became established as an effective therapy for rickets.30 
Furthermore, haematoporphyrin (a porphyrin derivative) was the first molecule developed specifically 
for ROS production (1908).31,32 





handful of photosensitizers are clinically available for the treatment of diseases such as cancer and 
macular degeneration.33 A major factor for why few photosensitizers commercially exist (besides the 
long time for pharmaceuticals to receive clinical approval) is because designing an effective 
photodynamic system has several requirements, each which create a unique set of challenges: 1.) Light 
must be able to penetrate the region of interest (ROI) 2.) After photo-excitation, the photosensitizer 
must be able to produce reactive oxygen species in a sufficient quantity to kill the ROI (group of cells, 
cancerous tissue, etc.), and 3.) The photosensitizing molecule must accumulate in the ROI and have no 
systematic toxicity. Each of these three requirements for an effective photosensitizer are discussed 
below. 
1.) Light Penetration into Tissue 
To perform photodynamic therapy, by definition, light serves as the mode to deliver the therapy. 
However, light penetration into tissue is highly dependent on wavelength, with redder 
wavelengths penetrating deepest into the skin. In fact, transitioning from 400 nm (blue) to 800 
nm (near-infrared), light penetration depth into tissue can change by a factor of 10-100x.34 
Because redder wavelengths penetrate deeper into tissue, using near-infrared light (IR) is most 
desirable for sub-surface PDT.34 However, ROS production efficiency begins to lose efficiency 
beyond 650 nm, as the energy required to create reactive oxygen species may not be met.35 By 
~850 nm, an electronic transition will not have enough potential to create ROS species.35 This 
means that in selecting photosensitizers, there is a battle between optimizing penetration depth 
(redder wavelengths) and efficiently producing ROS species (bluer wavelengths). For one-photon 
photosensitizers, the efficiency problem is a major reason why few infrared single-photon dyes 
(700+ nm) exist, although development of IR-PDT agents is a major field of active research.36 The 
issue of penetration depth versus reaction efficiency can also be resolved utilizing two-photon 





2.) Efficient Production of Reactive Oxygen Species (ROS) from the Photosensitizer 
Given that using near-infrared light is most desirable for sub-surface PDT, molecules must be 
discovered which 1.) Absorb the target wavelength efficiently (high absorption coefficient for 
electronic excitations, ideally in the near-infrared) and 2.) Produce efficient ROS. Typically, finding 
molecules to absorb in the near-infrared is the lesser of these two challenges. Many small 
molecule dyes and metals exist which absorb between 700-900 nm, like chlorin, phthalocyanine, 
BODIPY, cyanine, and KFL based molecules.36 However, as mentioned in 1.), the efficient 
production of ROS becomes more challenging as redder wavelengths (650+ nm) are utilized. 
Assuming that the energetic requirements are sufficient (energy difference between ground and 
excited state), ROS production efficiency is largely determined by the excited state lifetime of the 
photosensitizer.35 Overall, the longer the excited state lifetime, the more efficient ROS production 
will exist. This is because triplet oxygen will have more time to interact with the photosensitizer 
and convert triplet oxygen to singlet oxygen, when then forms and other ROS species. Following 
such a trend, the best photosensitizers have the longest excited triplet state lifetimes. Note that, 
by quantum mechanical selection rules, the original molecular excited state has to have the same 
multiplicity as the ground state, so as to have a strong optical absorbance, but then has to decay 
into a lower excited state with different multiplicity (with the aid of “relativistic quantum 
mechanics effects”), so as to efficiently excite the O2 molecule from its triplet ground state to its 
excited singlet state, an intersystem crossing transition. For example, Rose Bengal, with an ROS 
conversion efficiency of 70%, has an phosphorescent lifetime in the millisecond range (150 ms).37 
However, designing molecules with high ROS efficiency is highly challenging, as most molecules 
do not naturally possess long excited state lifetimes.  





If a photosensitizer absorbs in the near-infrared and has optimal ROS production efficiency, for 
photodynamic therapy to be effective, the photosensitizer must still accumulate in the region of 
interest (ROI) and cause no systemic toxicity to the patient. For accumulation of a photosensitizing 
molecule inside the human body, several challenges exist: the photosensitizer must be soluble in 
the blood (i.e. have water-like solubility) and reach the ROI effectively. Despite having desirable 
optical properties, many photosensitizers have poor solubilities, uptake efficiencies in cells, or 
exhibit toxicity, rendering them unusable. Furthermore, the properties of many photosensitizers 
are highly sensitive to solvent environment.  
1.2.2 Why Are Nanoparticles Good Candidates for PDT? 
Nanoparticles are good candidates for PDT as carriers of small molecule photosensitizers. For 
example, polyacrylamide (PAAm) nanohydrogels can be loaded with small molecules both inside the 
hydrogel shell and outside the surface of the nanoparticle.22 To protect the solvent environment of the 
photosensitizer, it is often most ideal to load the polyacrylamide nanohydrogel with the photosensitizer 
internally. To do this, if the photosensitizer is water soluble, it can be added during the synthesis of 
polyacrylamide hydrogels in the water phase before polymerization.20 Once polymerization commences, 
the photosensitizer will be trapped inside the polyacrylamide hydrogel that forms. In addition to loading 
photosensitizers internally, photosensitizers can be loaded externally. For example, nanoparticles with 
amine functional groups on their surface can be directly conjugated to photosensitizers via an 
isothiocyanate functional group or utilizing MAL (maleimide)-PEG-SCM (Succinimidyl Carboxyl Methyl 
ester)) linkers.38 As a model system, in the case of the PAAm nanoparticle, amine functional groups from 
the acrylamide and N-(3-Aminopropyl)methacrylamide hydrochloride (APMA) monomers have amine 
groups, therefore the former types of molecules (isothiocyanate functionalized and SCM-peg-NHS ester 
linkers) can bind to the surface of the PAAm nanoparticle. In the case of utilizing a MAL-PEG-SCM linker, 





For PAAm nanoparticles, this means that a variety of photosensitizer molecules can be utilized, as a variety 
of functional groups (isothiocyanate, thiol, etc.) to modify the molecule exist, and attached directly onto 
the nanoparticle via covalent interaction. In a typical paradigm, attaching a photosensitizer on the outside 
of the nanoparticle allows for ROS production to have a smaller diffusion distance into tissue, however 
the tradeoff is that the photosensitizer will not be kept in a consistent environment, as it will be directly 
exposed to the outside environment (ie tissue solvent). Hence, for different types of tissue and in different 
regions of the body (i.e. circulating in the blood/inside a cancer cell/inside a healthy cell), the properties 
of the photosensitizer may change if the photosensitizer is environmentally sensitive. For this reason, two-
photon photosensitizers,39,40 and even many one-photon photosensitizers (like methylene blue)41 should 
be conjugated inside the nanoparticle to protect their optical activity. 
1.2.3 Two-photon photodynamic therapy (2p-PDT) 
Two-photon photodynamic therapy is defined as photodynamic therapy that occurs via the 
process of two-photon absorption.42 In brief, two-photon absorption is the near-simultaneous absorption 
of two photons in which the energy of both photons is summed together during the quantized transition.43 
To determine the energy of the absorbed photon pair, the frequency of each photon should be summed 
together.43,44 For example, the frequency of a 400 nm (blue) photon is 7.494(10)14 Hz and the frequency 
of an 800 nm (near-infrared) photon is 3.747(10)14 Hz. When two 800 nm photons are absorbed via two-
photon absorption, the summed frequency is 7.494(10)14 Hz, equivalent to the frequency of a single 400 
nm photon. Hence, the energy transition of two-photon absorption with two 800 nm photons is 






Figure 1.3 One-photon absorption (400 nm; blue) and two-photon absorption (800 nm; red) electronic 
processes compared side-by-side. One-photon absorption of a photon proceeds directly to the excited 
state (g->n). In contrast, two-photon absorption involves an intermediate ‘off-resonance’ excited state (g-
>m->n), whereby a second photon is absorbed to reach the excited state electronic transition. 
A simplified diagram of the two-photon ‘electronic transition’, compared to its one-photon 
counterpart, is shown in Figure 1.3. Of important note is the inclusion of the ‘off-resonance’ excited 
state, as labeled in between the absorption of photons 1 and 2 in the two-photon process. In most 
introductory two-photon literature, this transition will most commonly be labeled as a ‘virtual state’. 
However, this naming convention has been criticized by experts in non-linear optics, because ‘virtual 
state’ is neither an intuitive term (does ‘virtual’ mean that the photon never existed in that state?), nor 
does it capture the photophysics of the two-photon absorption process. Instead, it has been proposed 
to better call this state an ‘off resonance’ excited state, which avoids the metaphysical ambiguities that 





 The advantage of two-photon absorption over one photon absorption largely lies in photon 
penetration depth: the photon penetration depth is greater by a factor of approximately 10 for 800 nm 
photons compared to 400 nm photons.42 Furthermore, whereas single 800 nm photons typically do not 
have the transition energy to produce ROS,35 two 800 nm photons far surpass the energy required to 
produce ROS. This means that reactive oxygen species can be produced via near-IR two-photon absorption 
1.) With deep penetration depth, solving the photon penetration depth problem, and 2.) With high 
potential cell-kill efficiencies due to the ROS energy production limit being met. 
 
Figure 1.4 Laser setup for two-photon photodynamic therapy.  
 A summary of a two-photon photodynamic therapy setup, used to induce in vitro 2p-PDT, is 
provided in Figure 1.4. By using an 800 nm pulsed laser, samples can be illuminated at highly ‘peak power’ 
intensity to induce the two-photon transition. The neutral density (‘ND’) filter allows the excitation power 
to be finely adjusted, and the beam size is measured by calculating the diameter of the Airy disk that forms 





1.3 Nanoparticle-based Microscopy: Dark Field Imaging and Tunable NPs 
1.3.1 Plasmonic Nanoparticles in Microscopy 
Metal nanoparticles are some of the most useful tools for nanomedical applications, like in 
microscopy-based imaging, photothermal therapy, and chemical sensing. Metal nanoparticles above 5 nm 
have desirable optical properties due to exhibiting plasmon resonance. In brief, plasmon resonance is the 
resonant oscillation of conduction electrons (‘collective oscillations’) in a metal.45,46 The frequency of 
these electron oscillation creates a plasmon, a quasiparticle that can couple to photon oscillation.45 
Furthermore, since plasmons are the quantization of classical plasma oscillations, their properties can be 
derived from Maxwell’s Equations (classical theory).46 While metals like gold exhibit plasmonic effects at 
the bulk level (accounting for their specific color), metal nanoparticles are unique in that tuning the 
plasmonic interaction (thus “color”) is possible. For example, the size of the nanoparticle and the 
geometry of the nanoparticle are both highly conductive towards photon-NP interactions. For gold 
nanospheres, the optical extinction maxima can be tuned from 520 nm (9 nm) to 585 nm (99 nm) by 
changing the NP size.47,48 However, extending the plasmonic peak beyond 585 nm represents a major 
challenge, as larger gold nanoparticles have broad absorbance spectra with low peak specificity.48 
Furthermore, beyond 250 nm, the utility of large Au nanospheres becomes less practical for biological 
application. Lastly, fine spectral resolution control (i.e. <5-10 nm) of plasmonic extinction spectra cannot 
be easily obtained using sphere synthesis, as finely controlling the gold nanoparticle size presents a large 
practical challenge. 
1.3.2 Applications of Metal Plasmonic NPs: Dark-Field Microscopy 
Dark field microscopy describes an imaging modality in which light is focused onto a specimen, 
however a block is typically inserted after the sample to prevent direct imaging.49 In addition, slits are 
made far from the center of the specimen plane, with an objective following each slit, to collect signal at 





image, whereas directly transmitted light will be blocked.49 A summary of a typical dark-field microscopy 
setup is provided in Figure 1.5. 
 
Figure 1.5 Dark field microscopy optics. The incoming light is focused onto the specimen, whereby a beam 
block is used to block the traditional ‘light microscope’ direct image of the sample. Instead, at sharp 
angles, scattered light is focused onto the detector to form an image. 
Dark field imaging has advantages that traditional light microscopy does not offer. For example, 
dark field imaging allows one to image cells almost entirely free of artifacts.49 Foremost, artifacts due to 
the main beam are blocked, including interference patterns and fringing. Secondly, cell artifacts like 
autofluorescence are minimized as the collection angle of the dark-field image can be optimized based on 
the wavelength of the light scattered. Since plasmonic metal nanoparticles are highly scattering, they are 
frequently used as contrast agents for dark-field imaging.50 However, as mentioned previously, the 





element selected, size of the nanoparticle, and morphology of the nanoparticle. In the next two sections 
(1.3.3 and 1.3.4), basic theory is outlined for the optical properties of metallic nanoparticles.  
1.3.3 Free Electron ‘Drude’ Model 
Utilizing computation to determine the properties of plasmonic NP optical materials is imperative, 
as modern theories are highly developed and accessible. The most basic model of plasmonic behavior is 




= ℏ𝜔𝑝 (1.1) 
Where 𝐸𝑝 is the plasma energy, n is the conduction electron density, e is the elementary charge, m is the 
electron mass, 𝜖0 is the permittivity of free space, and 𝜔𝑝 is the plasmon frequency. 
Since e, m, and 𝜖0 are constants, 𝜔𝑝 depends on the conduction electron density between metals 
(n). The conduction electron density is given by 𝑛 = 𝑍𝑁𝜌𝑚/𝑚; where Z is the number of conduction 
(valence) electrons per atom, N is the Avogadro constant, 𝜌𝑚 is the density of the solid (atoms/m
3), and 
M is the atomic mass (kilograms/atom).51 Furthermore, by modeling the light-plasmon interaction by 
solving the differential equation for the well-known damped harmonic oscillator (see Mohammadzadeh 
et. al. for full derivation), one can see that absorption occurs when 𝜔𝑝 = 𝜔𝑙𝑖𝑔ℎ𝑡.
52 
 For metals like gold and silver, the plasma frequency is in the ultraviolet (139.45 nm, 137.14 nm 
respectively).53 While the Drude model accurately models the plasmon behavior of bulk metals, it fails to 
model the behavior of nanoparticles systems with ‘confined’ inner electrons. Furthermore, while modified 
Drude models to account for nanoparticle behavior are in early development, more established models 
of determining the optical properties of nanoparticles are in place.52 In the next section, 1.3.4, we briefly 
describe Mie Theory and the Discrete Dipole Approximation (DDA), which can be utilized to determine 





1.3.4 Mie Theory and Discrete Dipole Approximation 
Mie Theory is an analytical solution of Maxwell’s Equations for the scattering of electromagnetic 
radiation interacting with particles of arbitrary size. Mie Theory is typically divided dependent on two 
parameters 1.) m, the magnitude of refractive index (n) mismatch between scattering particles and the 
host medium where m = np/nmed, and 2.) x, the size parameter of the scattering particles, determined by 
the ratio of the circumference of the particle to the wavelength of light (x = 2πa/(λ/nmed).54 The Mie 
Solutions to electromagnetic scattering are described in detail by Bohren and Huffman.55 Using their 
notation, the Mie coefficients an and bn compute the amplitudes of a scattered radiative field, whereas cn 
and dn compute the amplitude of the internal field. For particles that are small compared to the radiative 
wavelength, Bohren and Huffman derive the absorption and scattering coefficients of a homogenous, 
isotropic sphere utilizing a power series expansion of spherical Bessel functions (canonical solutions to 
Bessel’s differential equation).55 However, Mie Theory has severe limitations, as the solutions to the wave 
equation have only been solved for limited geometries. 
Instead of using a Mie-based approach, which requires an exact analytical solution of light 
interacting with a continuous object, other methods have been developed to model light-particle 
interactions. The discrete dipole approximation (DDA) is one of the most developed, and diverse, classical 
solutions to the scattering problem.4 The discrete dipole approximation works by discretizing a continuous 
object into point dipoles. Whereas complex, continuous objects may not have solvable analytical solution 
to the wave equation, light interacting with a series of point dipoles has a known solution. Hence, by 
building geometries of point-dipoles, the optical properties of the material can be solved. Figure 1.6 shows 
point-dipole input of a sphere for input into DDSCAT. As Figure 1.6 shows, as dipole number is increased, 
the object more closely resembles the spheroid. This principle demonstrates that higher dipole numbers 






Figure 1.6 Geometry of a spheroid for typical input into the DDSCAT (‘Discrete Dipole Scattering’) package. 
As the number of dipoles is increased, the target object will be closer to its continuous morphological 
analogue (i.e. sphere in above case).  
To study nanoparticle systems >5 nm, DDA-based approaches are frequently employed. We use 
the DDSCAT (‘Discrete Dipole Scattering’) package to simulate the optical properties of gold nanoparticles.  
1.3.5 Gold Nanochains: A New Kind of Plasmon  
Chapter 4 discusses the development of gold nanochains, tunable plasmonic nanosystems 
obtained from the polymerization of nanospheres. Within Chapter 4, we develop a protocol to “grow” 
nanospheroid-monomers into chain-like structures, example nanochain structures which are shown in 
Figure 1.7. Once the nanochains grow to the desired length, growth of the chain can be quenched by 
adding conjugated polyethylene glycol (PEG) capping moieties. In growing the plasmonic nanochain, the 
optical extinction coefficient can be tuned with approximately 1 nm resolution from 590 nm – 640 nm. In 






Figure 1.7 Plasmonic nanochains (‘nanosnakes’), grown from Au nanospheroid monomers into linear 
morphologies. The average Au monomer is 20 nm in diameter. 
As mentioned in 1.3.1, creating spherical plasmonic nanoparticles (monomers) with plasmonic 
resonance beyond 585 nm has technical barriers. At sizes beyond that of 100 nm gold NPs (585 nm 
resonance), the optical extinction spectra of the nanosphere becomes unfocused and red-shifting 
becomes insignificant. However, in synthesizing gold nanochains, we can tune the optical extinction 
spectra to up to 640 nm and beyond. While Chapter 4 covers tunable plasmonic nanochains from 590 – 
640 nm, we have also synthesized tunable chains with optical extinction maxima up to 700 nm using the 
same protocol.  
1.4 Nanoparticles and Targeting 
1.4.1 What is Active Targeting? 
Due to the differentiation of cells in the body, the receptors on the surfaces of different cell types 
vary. Furthermore, when cells become aberrant (cancerous, proliferating) the surface receptors further 
differentiate. Because of the variety in receptor expression, receptor heterogeneity can be utilized for 
active targeting. In short, active target describes the process of utilizing a small molecule, protein, or 
antibody that has a strong affinity for a specific cell receptor.12,56 Furthermore, when this material is 
injected into a specimen, due to receptor expression heterogeneity, the material targets preferentially to 





based active-targeting paradigm. After disease diagnosis, nanoparticles with targeting moieties are 
injected into the patient. Due to targeting specificity, the nanoparticles will localize to the tumor region, 
where therapy can be treated locally.  
Figure 1.8 Nanoparticle-assisted active targeting in the case of photodynamic cancer therapy. 
When active targeting moieties are added to nanoparticles, active targeting can increase 
nanoparticle localization by several factors (2-5x for many active targeting moieties, >10x in rare cases).12 
Chapter 5 of the thesis will explore nanoparticle-based active targeting for macular degeneration (MD), 
also known as retinal neovascularization. The following section will briefly underly the utility of active 
targeting to treat MD. 
1.4.2 Macular Degeneration and Targeting 
Macular degeneration is the leading cause of progressive vision loss among people older than 60 
in developed countries, and affects 10% of people over 75.57,58 While there are several different types of 
age-related macular degeneration (AMD), choroidal neovascularization is an aggressive form of AMD (10% 
of cases) that is caused by the angiogenesis of endothelial cells that invade the subretinal space, which in 
turn causes photoreceptor loss and vision degeneration. While neovascular AMD is non-cancerous, the 
neovascularization process is “like a cancer” in that endothelial vessel formation becomes overregulated, 





corollary biological factor that triggers retinal neovascularization, as hypoxia incudible factor 1 (HIF1) 
becomes overexpressed in cells, leading to VEGF overexpression. Following the hypoxia model, hypoxia 
also alters the signaling pathway of β-adrenergic receptors. The increased activity of the β-adrenergic 
pathway is linked to increased VEGF production.59 Overall, the biological causes of macular degeneration 
are complex, and continue to be elucidated. Due to the complex model of MD, we explore several 
potential targeting agents for MD therapy. Namely, within Chapter 5, we develop a peg-based nanosystem 
for targeting to MD regions, with RGD peptide and iobenguane (MIBG)-derivates as a potential targeting 
agents.  
1.5 Outline of Dissertation 
Chapter 1 of this dissertation defines and introduces bio-based nanoparticles (NPs) and introduces 
key concepts for photodynamic therapy (Ch. 2), dark field imaging (Ch. 3), macular degeneration (Ch. 4), 
and biological targeting (Ch. 4).  
Chapter 2 introduces a new nanoparticle, Au25Capt18-Polyacrylamide (PAAm) NPs for applications 
in two-photon photodynamic therapy. We demonstrate highly efficacious in vitro two-photon PDT for 
these PAAm-Au25Capt18 NPs, exhibiting a tremendous enhancement in 2p-PDT-mediated cell death over 
one-photon PDT-mediated cell death. We demonstrate that this enhancement is associated with the 
high non-linear optical absorbance cross-section of the Au25 NC. Furthermore, we show that as a new 
two-photon photodynamic agent, the Au25Capt18cluster, (a) has a two-photon cross-section 8x larger 
when compared to 5,10,15,20-Tetrakis(1-methyl-4-pyridinio)porphyrin tetra(p-toluenesulfonate) 
(TMPYP), the currently most used two-photon photosensitizer, (b) has modest reactive oxygen species 
(ROS) production (1%) under two-photon excitation, with the potential for this efficiency to be further 
improved, and (c) when embedded in hydrogel NPs it maintains its unique optical properties while 





Chapter 3 describes the synthesis and characterization of Au plasmonic nanochains for imaging 
applications. We fabricate and characterize highly linear plasmonic nanochains of gold nanospheres, 
which we call “nanosnakes”. These nanosnakes are self-assembled from bare Au nanosphere monomers 
with virgin surfaces, produced in DI water by laser ablation (a green, chemical-free synthesis), where the 
monomers are surface conjugated with small, biocompatible molecules so as to induce their assembly. 
These nanosnakes have several highly desirable properties for biological imaging, including two 
plasmonic modes, one fixed mode at 525 nm (monomer mode) and a second highly tunable mode. The 
secondary tunable mode ranges from 590 nm to 640 nm, with tunability precision within 1-2 nm. Such 
tunability towards the infrared is a highly desirable property in plasmonic imaging, due to these 
photons’ deeper tissue penetration as well as due to their much reduced background cell fluorescence. 
We also show that the nanosnakes possess scattering cross-sections up to 40x higher than the Au 
nanosphere monomers (approximately 3x higher per chain monomer nanosphere), thus making them 
better contrast agents for imaging applications, noting that gold NPs are utilized for both dark-field and 
X-ray imaging. Lastly, we demonstrate that the nanosnakes can be easily conjugated with active 
targeting moieties, for applications such as targeted cancer and heart disease phototherapy, using the 
RGD peptide as a model system; furthermore, we show that they are also non-toxic to cells, even at very 
high concentrations, up to concentrations as high as 0.25 mg/mL NP mass concentration (OD:5). Overall, 
the nanosnakes represent a promising new imaging modality for dark-field, SERS, and high resolution 
microscopy, and have a high potential for in vivo theranostic applications. 
Chapter 4 describes the development of targeted nanosystems for the diagnosis of macular 
degeneration, wherein we evaluate fluorescent 8-arm-peg NPs for their RGD-assisted targeting to the age-
related macular degeneration (AMD) neovasculature. In vitro experiments reveal a strong, measurable 
difference between non-targeted and RGD targeted NPs, with the RGD targeted NPs showing nearly a 100 





with the highest incubated NP concentration (3 mg/mL) providing the greatest in vitro contrast. In vivo 
experiments at high incubated PEG-RGD concentrations (20 mg/mL injections) show approximately 15-
20% enhancement in targeting signal, when compared to non-RGD controls. Overall, we show that 8-arm 
PEG NPs are a new, readily conjugatable and targetable nanosystem for future optimized AMD diagnosis 
and therapy, with potential benefits for in vivo theranostic enhancement. 
Lastly, Chapter 5 is the conclusion to this dissertation, summarizing key points and future implications 
from Chapters 2-4.  
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Chapter 2: Synthesis and Optical Properties of Two-photon Absorbing Au25Captopril18-Embedded 
Polyacrylamide Nanoparticles for Cancer Therapy 
2.1 Abstract 
 Au25(Captopril)18 nanoclusters (NCs) are a 1.2 nm water-soluble metal nanomaterial with strong 
two-photon absorption, excited-state reactive oxygen production, and of potential applicability for 
biomedical imaging and 2-photon photodynamic therapy (2p-PDT). Due to the low cellular uptake of 
Au25(Captopril)18 clusters, its limited potential for conjugation with targeting agents, and to enhance its 
biocompatibility, we embedded these clusters into hydrogel nanoparticles (NPs), by synthesizing 
polyacrylamide-encapsulated Au25(Capt)18 nanoparticles (PAAm-Au25(Capt)18 NPs). We verified that the 
two-photon absorption and singlet oxygen production of these PAAm-Au25 NPs still exhibit the favorable 
properties of the original metal nanocluster. Furthermore, the Au25-encapsulated polyacrylamide 
nanoparticles have enhanced in vitro cell uptake, can be easily conjugated to targeting moieties, and 
exhibit significantly higher biocompatibility. Photo-irradiation experiments on HeLa cancer cells 
incubated with these PAAm-Au25(Capt)18 NPs reveal excellent 2p-PDT efficacy, in contrast to 1p-PDT, 
thus demonstrating their promising potential for cancer PDT with infrared light that penetrates deeply 
into live tissue. 
2.2 Introduction 
Au25 nanoclusters are ultra-small (<2 nm), highly unique, molecular nanomaterials, with 
promising applications to biomedicine,3–6 catalysis,7–9 and energy storage.10,11 Regarding biomedical 
applications, Au25 nanoclusters have a promising potential for two-photon photodynamic therapy (2p-
PDT). Two-photon photodynamic therapy is the process of using two low energy photons, in a non-linear 





dye’s excited state (ES), to triplet oxygen molecules (O2), produces reactive oxygen species (ROS). 
Because reactive oxygen species are cytotoxic, this process can be used to elicit the death of anomalous, 
pathology driving cells, but only in the highly selectively excited tissue regions.12–14 At the molecular 
level, two factors dictate the efficacy of photodynamic therapy dyes: optical absorbance and reactive 
oxygen production efficiency.15 Since Au25 clusters display high polarizability under photo-excitation, 
they have extremely high two-photon cross-sections (high optical absorbance).16,17 In addition, the Au25 
nanoclusters have been shown to produce reactive oxygen species (ROS) upon photo-excitation. For 
example, Au25 clusters have been used to generate reactive oxygen for ROS-mediated chemical 
conversion with yields as high as 50%.18 Au25 is also an ideal photodynamic therapy candidate because 
near-infrared light (800 nm) is used for its excitation. Using such near-IR light has two advantages: 1. 
Negligible photodamage and 2. Near-IR light exhibits the lowest scattering and thus the deepest 
penetration into the skin and tissue, making near-IR wavelengths most desirable for sub-surface PDT.19 
Since the availability of one-photon near-IR PDT agents is limited, two-photon PDT agents like Au25 need 
be explored.20 A schematic of the two-photon PDT process for Au25(Capt)18 clusters is given in Figure 2.1. 
In this figure, incoming light (red) represents 800 nm pulsed light leading to strong two-photon 
absorption into the excited state (ES), followed by the triplet to singlet oxygen (O2) conversion required 
















Figure 2.1 Schematic of reactive oxygen production from Au25 nanoclusters upon two-photon excitation, 
where ES is the excited state. The example Au cluster shown in this figure is Au25Captopril18 and a TEM of 
the 1.2 nm clusters is provided. 
Gold nanoclusters of other sizes exist (i.e. Au4, Au15, Au28, Au38, Au44, Au144)17,21,22, however, Au25 
should be viewed as the most substantiated candidate for two-photon PDT applications. To evaluate 
molecular absorbance efficiency among nanocluster materials, the “Two-photon Absorption/Volume” 
ratio (A/V) has been established as an important parameter.23 Au25, Au38, and Au144 clusters have radii 
ratio of 0.5 nm, 0.65 nm, and 0.8 nm and two-photon cross-section coefficients of 2.0(10)-10, 3.5(10)-10, 
and 7.0(10)-10 (m/W), respectively.24,25 Among these clusters, Au25 has the best A/V ratio (1.0 vs. 0.80 
and 0.85 W-1m-2). Furthermore, we note that while larger Au clusters, like Au144(C6H13S), have a more 





the other hand, smaller Au clusters like Au15 have a high (A/V) ratio, but no proven utility for reactive 
oxygen production, even under one-photon excitation.26  
Among the Au25 variants, most are impractical for in-vivo applications, as few are soluble in 
water. Notably, water solubility enables embedding in nanogels. Au25(SG)18 (SG = C10H17N3O6S), the most 
characterized Au25 water soluble nanocluster, has been explored for in-vitro two-photon photodynamic 
therapy.23 The here presented Au25(Captopril)18 – or Au25(Capt)18 -- is a new generation, water soluble, 
Au25 nanocluster with significantly higher thermal stability than the glutathione (SG) cluster.27,28 
Au25(Capt)18 has been shown to produce reactive oxygen with 420-460 nm excitation.18,29 In addition, an 
Au25(Capt)18 in vitro one-photon PDT efficacy, even with a concentration as low as 5 µg/mL, was also 
demonstrated under 420-460 nm excitation.29 While Au25(Capt)18 has improved thermal properties and 
proven reactive oxygen generation, efficient cellular targeting with Au clusters is a major challenge for 
biomedical applications, as cell uptake is low.30 Furthermore, as we show, high incubation 
concentrations (>0.1 mg/mL) of these nanoclusters negatively affect cellular metabolism and viability.  
To increase cellular uptake and biocompatibility, we have developed larger, biocompatible 
polyacrylamide nanohydrogels to encapsulate the gold cluster. Polyacrylamide nanohydrogels (PAAm) 
have been used before to encapsulate photodynamic agents, exhibiting in vitro targeting efficiencies 
beyond 90%.31 Furthermore, polyacrylamide particles do not produce acute organ damage or other 
measurable signs of toxicity.32,33 In addition, polyacrylamide nanoparticles benefit from the enhanced 
permeability and retention (EPR) effect in vivo and can be conjugated with cancer cell targeting 
peptides.33,34 Lastly, for two-photon absorbing molecules specifically, it is important to provide a 
protected, stable environment, as the two-photon cross-section is highly sensitive to local protein 
electric fields.35,36 As such, polyacrylamide nanohydrogels have a highly stable solvent environment, 





In this work we investigate the potential of polyacrylamide-encapsulated Au25(Capt)18 for two-
photon photodynamic therapy (2p-PDT). In synthesizing Au25(Capt)18 nanoclusters inside of the 
polyacrylamide nano-matrix,33,38 we find the favorable two-photon absorption and singlet oxygen 
efficiency to be preserved between the metal nanocluster and this cluster when encapsulated in 
polyacrylamide. Furthermore, in comparing Au25 and the encapsulated PAAm-Au25, we find that PAAm-
Au25 has better targeting to cells and has significantly higher biocompatibility compared to non-
encapsulated Au25. Finally, we find that, in complete contrast to 1p-PDT, PAAm-Au25(Captopril)18 
nanoparticles exhibit high efficacy under 2p-PDT excitation. The latter is of high significance for potential 
in-vivo PDT. 
 
2.3 Experimental Procedures 
2.3.1 Synthesis of Au25(Capt)18. 
 
160 mg of HAuCl4·3H2O and 250 mg of tetraoctylammonium bromide (TOABr) were first dissolved in 30 
mL of methanol, and the solution was vigorously stirred for ~15 min until the color changed from yellow 
to deep red. Then, 435 mg of captopril was rapidly added to the above reaction mixture under stirring; 
the solution color quickly changed to white. After ~60 min, 150 mg of NaBH4 (dissolved in 7 ml of ice-cold 
water) was rapidly added to the reaction mixture under vigorous stirring; the solution color immediately 
turned brown-black. The reaction was allowed to proceed for 24 to 48 h under constant stirring, during 
which a spontaneous “size-focusing” process occurred, with the unstable clusters decomposed or 
converted, giving rise to pure Au25(Capt)18 nanoclusters with the characteristic UV-vis absorption peaks at 






Figure 2.2 Synthetic steps to synthesize the Au25Capt18 cluster. Color changes (left to right; top to bottom) 
are bright yellow, fluorescent red, cream white, and dark black/purple for each synthetic step accordingly. 
After the reaction, the mixture was first centrifuged to remove the unreacted, insoluble Au(I):SR polymers 
(4000 g; 5 min). The supernatant was collected and concentrated by rotary evaporation. The Au25(Capt)18 
clusters were precipitated by adding excess ethanol to the solution, followed by centrifugation (4000 g; 
30 min). The collected Au25(Capt)18 precipitate was washed with ethanol several times (3x) and finally 
dried under vacuum. Typically, ~15 mg Au25(Capt)18 with high purity can be obtained in such a synthesis. 
2.3.2 Synthesis of PAAm-Au25(Capt)18 Hydrogel Nanoparticles. 
A solution of 10 mL hexane, 0.357 g AOT, and 0.733 mL Brij30 was added to a 25 mL RB flask and purged 
under argon while stirring for 20 minutes.39 Brij was weighed gravimetrically for increased accuracy. The 
particles were stirred at 600-700 RPM. 122.67 mg of acrylamide and 9.33 mg of APMA were dissolved in 
0.31 mL of PBS, and 43 mg of AHM was added. Next, 15 mg of Au25(Capt)18 was added to solution. The 
PBS solution was then injected dropwise into the hexane solution, followed by 33.33 microliters of 





and the remaining particles were washed 5 times with ethanol, followed by 5 washes with water. After, 
samples were freeze-dried and stored under freezing. 
 
2.3.3 Transmission Electron Microscopy. 
JEM 1400 TEM: Transmission electron microscopy was performed using a JEOL JEM 1400 electron 
microscope at 80 kV in vacuum. Samples were loaded onto a pre-plasma oxidized 200 well copper grid. 
For loading, a 5 μL sample of PAAm-Au25(Capt)18 prepared at 20 mg/mL was drop-added onto the grid. 
After waiting 30 seconds, a piece of #1 Whatman filter was used to wick the liquid on the edge of the 
grid. Next, after drop-washing with 5 μL of distilled water, a sample of 5 μL 1% uranyl acetate was 
applied. After 3 minutes of incubation, the #1 Whatman filter was used to remove any excess uranyl 
acetate stain.  
 
JEM 2100F High Resolution STEM (scanning transmission electron microscopy): A JEOL JEM 2100F with a 
CEOS STEM corrector mounted was used for imaging the Au25 samples working in STEM mode. Both 
STEM bright-field (BF) and High angle annular dark-field (HAADF) images were taken simultaneously. The 
specimen in the STEM study was prepared by placing a drop of a sample solution (20 mg/mL) on a 
Holey-carbon film coated Cu grid and let to dry before loading it into a TEM holder. 
 
 
2.3.4 One-photon Absorption and Fluorescence. 
 
Absorption was measured using a Shimadzu UV-Vis. All samples were prepared in 1 cm disposable 
cuvettes in PBS (Au25Capt18, PAAm-Au25Capt18) or methanol (Coumarin 183). Fluorescence 
measurements were performed using a Horiba Floromax 4 instrument. Samples were prepared at dilute 





emission spectra, the intensity was adjusted using the Horiba calibration file (MCORRECT) to account for 
detector efficiency. 
 
2.3.5 Two-photon Excited Fluorescence (TPEF) Cross-Section Measurement. 
The two-photon cross-section was measured using the TPEF method.40 A mode-locked 100 fs pulsed 
TI:Sapphire laser with a repetition rate of 80 MHz was focused onto the sample at 800 nm excitation and 
the fluorescence was collected by an Acton Instrument SpectraPro 3000 with a Hamamatsu 928 PMT set 
at 800 V. Input power from the laser was varied using a neutral density filter. Coumarin 307 dissolved in 
methanol was used as a reference (δɳ800 = 14.7 GM).40 Vitamin C was added to all samples at 1 mg/mL to 
prevent sample degradation under high power laser irradiation. A vitamin C control was run to observe 
no laser-induced fluorescence.  
The equation below, stemming from Equation 15 in Xu et. al40, gives the relationship between 
fluorescence and two-photon cross-section of a given molecule, 






 ]  (2.1a) 
where F(t) is the two-photon fluorescence, P(t) is the excitation power, n is the refractive index of the 
solvent used, [c] is the concentration of the molecule (M), ɳ is quantum yield of the molecule, δ is the 
two-photon cross-section of the molecule, λ is the laser wavelength, and gp ‘second order temporal 
coherence’, f ‘rep rate’, and t ‘FWHM’ are laser parameters which are experimentally constant during 
collection.  
 The above formula is written in the y = mx + b form and applied in the TPEF method via a 
ratiometric comparison between a known two-photon dye and the sample. Hence, the two-photon 
cross-section is calculated using Equation 2.1b, where δ is the two-photon cross-section, b is the y-










  (2.1b) 
The y-intercept is found by measuring the two-photon fluorescence at multiple powers of 
excitation, and plotting log[Fluorescence] vs. log[Power]. As equations 2.1a and 2.1b reveal, larger y-
intercepts will result in larger cross-sections; for molecules with large two-photon cross-sections, we 
expect the y-intercept (b) to be non-zero. 
 
2.3.6 Singlet Oxygen Detection via SOSG. 
Singlet oxygen sensor green (SOSG) was used to measure the singlet oxygen production of Au25(Capt)18, 
PAAm-Au25(Capt)18, and TMPYP (5,10,15,20-Tetrakis(1-methyl-4-pyridinio) porphyrin tetra(p-
toluenesulfonate)). TMPYP was chosen for comparison to Au25 as it is a popular photosensitizer, with two-
photon properties.41–44 Rose Bengal (RB) was used as a standard, with singlet oxygen efficiency of 0.75 at 
549 nm excitation in PBS.45 All samples were adjusted to have the same optical density (OD = 0.093) in 1 
mL PBS solution, measured via UV-Vis on a UV-2600 from Shimadzu Scientific Instruments, Inc. For each 
sample of identical OD that was prepared, 6 μM of SOSG (20 μL of 0.3 mM stock) was added to the cuvette 
and stirred for 5 minutes. Next, the samples brought to the fluorimeter (Horiba Fluoromax 4c). 
Photosensitizers were excited on the fluorometer in 10 minute intervals of 10, 20, 30, and 40 minutes 
(total excitation time) using 5 nm excitation slit and 1 nm emission slit. Rose Bengal (RB) was excited at 
549 nm, and PAAM-Au25(Capt)18, Au25(Capt)18, and TMPYP samples were excited at 400 nm. PBS controls 
were additionally prepared, excited at 400 nm and 549 nm respectively, to reveal that SOSG had no 
sensitivity to either wavelength without photosensitizer. Before each excitation, SOSG fluorescence (504 
nm excitation; 520 – 600 nm emission) was collected with 1 nm excitation and emission slits with an 
integration time of 0.1 seconds. As singlet oxygen is produced, SOSG will increase in fluorescence.46,47 To 
calculate the singlet oxygen efficiency of each photosensitizer, the fluorescence increase of SOSG at 530 













2.3.7 Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Experiments. 
Determining Mass Loading of Au25(Capt)18 in PAAm-Au25Capt18 
ICP-MS was run using a Perkin Elmer Nexion 2000. A gold standard (Au 197) was prepared at 1, 2, 3, 4, 
and 5 ppb in Milli-Q water with bismuth (Bi 209) as an internal standard. The PAAm-Au25(Capt)18 was 
prepared at 100 ppb (100 ng/mL) to determine the amount of Au present. ICP runs were averaged over 
3 trials. The counts of all samples were adjusted based on the Bi 209 standard, then a linear fit was 
determined from the known Au standards (y-intercept fixed at 0) to calculate the Au25(Capt)18 mass in 
PAAm-Au25(Capt)18.  
 
Determining HeLa Cell Uptake Efficiency of Au25Capt18 and PAAm-Au25Capt18 
100,000 Hela cells were plated two days before experiment. 24 hours before experiment, media was 
removed, cells were washed with 1 mL DPBS, and Au25Capt18 (0.1 mg/ml, 0.05 mg/ml, 0.025 mg/ml, 
0.0125 mg/ml, 0.00625 mg/ml) and PAAm- Au25Capt18 (2 mg/ml, 1 mg/ml, 0.5 mg/ml, 0.25mg/ml, 
0.125mg) were added to cell plates in 1 mL DMEM (10% FBS, 1% PS, 1% AA) media. The next day, plates 
were washed 2 times using DPBS, and 1 mL of 1% trypsin was added to each plate. Next, all samples 
were diluted (250 uL sample in 10 mL PBS). Cell samples incubated with high Au concentrations, namely 
Au25Capt18 (0.1 mg/ml, 0.05 mg/ml) and PAAM-Au25Capt18 (2 mg/ml, 1 mg/ml), were additionally diluted 
(500 mL of first diluted solution in 2 mL PBS). All samples were then analyzed on the Perkin Elmer 






2.3.8 HeLa Biocompatibility Measurements.   
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay is employed as a way of 
measuring whether any stress is placed on the cells by being in the presence of the NPs.49 Using a 96 
well plate, 5,000 HeLa cancer cells were plated in each well in 100 µL of DMEM media. The cells were 
incubated for 24 hours to ensure adhesion to the plate. The nanoparticles were then added to 5 wells at 
concentrations of 0.1, 0.3, 0.5, 1.0, 2.0, 5.0, and 10.0 mg/mL, and volumes were brought to 200 µL for all 
wells. A control sample was made without any nanoparticle treatment. After 24 more hours of 
incubation, 20 µL of a 0.5 mg/mL solution of MTT dye in PBS was added to each well. After 3 hours, the 
media was removed and replaced with 200 µL of DMSO. The plate was transferred to an Anthos 2010 
plate reader and scanned at 540 nm excitation. 
To calculate the viability, the raw data for each nanoparticle concentration was averaged (n=5) to reduce 
random error. Percent viability was normalized by dividing the average values for each nanoparticle 
concentration by the control average value. Error bars were determined from the standard deviation of 
the 5 wells for each sample. 
 
2.3.9 Two-photon photodynamic therapy and imaging microscopy. 
HeLa cells were plated at 150,000 cells/plate 2 days before the experiment. For non-controls, PAAm-
Au25 NPs were incubated at 0.5, 1.0, and 3.0 mg/mL one day before the confocal experiment. 24 hours 
later, media was aspirated and plates were washed with DPBS buffer. Next, 1 mL of DMEM media was 
added to all plates. 2.5 μl Calcein AM from a 50 μg/50 μL DMSO solution was added to the plate (2.5 
μL/1 mL of media). After 30 minutes incubation, the plate was washed 3 times with DPBS media. Next, 1 
mL of DMEM media was added to the plate and 20 μL of Propidium Iodide (PI) at 1 mg/mL was added 






Two-photon photodynamic therapy was performed using a SpectraPhysics Ti:Sapphire laser with a 100 
fs pulse width and a 80 MHz repetition rate at 100 mW/cm2, under 5 minute and 15 minute excitation, 
focused onto the sample using a 10x objective (Figure S1). Non-pulsed controls (one-photon) were 
performed for all samples. Microscopy images were taken using Calcein AM (exmax 495/emmax 515) and 
Propidium Iodide (exmax 535/emmax 617) filters in the excited region. After photodynamic illumination, 
Calcein AM and Propidium Iodide fluorescence was taken in fixed time intervals. 
 
 
2.4 Results & Discussion 
2.4.1 Synthesis and one-photon absorption of PAAm-Au25Capt18. 
 Au25(Capt)18 has absorption maxima at 456 nm and 678 nm in phosphate-buffered saline (pH 
7.4) as shown in Figure 2.2A. Polyacrylamide (PAAm)-Au25Capt18 embedded nanoclusters were 
synthesized using a reverse-micelle method.14 As shown in Figure 2.2A, both 456 and 678 nm peaks are 
present, confirming cluster integrity. The reduction in the peaks may be due to the external PAAm 
environment, as surrounding ligand has been shown to strongly influence Au25 absorbance.50 
Furthermore, as we show later in this manuscript, the two-photon absorption cross-section and singlet 
oxygen efficiency of the Au25Capt18 is preserved when embedded in PAAm, of importance for 2p-PDT. 






Figure 2.3 A.) UV-Vis spectra of Au25(Capt)18 nanoclusters and PAAm-Au25(Capt)18 embedded 
nanoparticles. B.) Transmission electron microscopy image of PAAm-Au25Capt18 NPs. C.) Energy dispersive 
X-Ray spectroscopy peaks of PAAm-Au25Capt18 deposited on a copper TEM grid. D.) High-resolution 
transmission electron microscopy image of polyacrylamide (PAAm) particle revealing encapsulated 
Au25Capt18 clusters (blue arrows point to Au25Capt18 NCs speckled in NP). 
Using dynamic light scattering, the average diameter of the polyacrylamide particles was found 
to be 26.5 nm and the polydispersity index (PDI) was 0.208, where PDI is defined by 
(STDEVdiameter2/(mean diameter)2).51 The PAAm PDI falls into the range of previously reported particles, 
and its PDI is below the 0.3 limit defined for monodisperse nano pharmaceuticals.51–53 The size of PAAm 
particles is confirmed by transmission electron microscopy (TEM), as shown in Figure 2.2B. Additionally, 





embedded in PAAm (Figure 2.2C). Within the EDS spectra, copper is also identified due to the use of a 
copper TEM grid and iron and cobalt due to the TEM lens. Using high-resolution transmission electron 
microscopy, the Au clusters are further visualized (Figure 2.2D, blue arrows). Based on the per mass 
absorption difference between non-loaded and loaded PAAm-Au25(Capt)18, the Au25(Capt)18 NC is about 
5% by mass of the total PAAm particle. Using inductively-coupled plasma mass spectrometry (ICP-MS), 
the Au25(Capt)18 loading was measured at 4.2% M/M% in PAAm, confirming the UV-Vis results (Figure 
2.3).  
 
Figure 2.4 ICP Results of PAAm-Au25(Capt)18 at 100 ng/mL calibrated against 1-5 ng/mL Au standards (R2 
=0.990). 
2.4.2 Two-photon cross-section and singlet oxygen efficiency of PAAm-Au25(Capt)18. 
 As mentioned previously, the absorption and singlet oxygen efficiency determine the molecular 
efficacy of photosensitizers.15 While Au25 clusters have weak one-photon absorption at 800 nm, Au25 
clusters are reported to have high two-photon absorption cross-sections at 800 nm.14,52,53 To measure 
the two-photon cross-section of nonlinear materials, the Z-scan method or TPEF (two-photon excited 
fluorescence) methods are most commonly used.52 However, since Au25Capt18 has both linear and non-
linear absorbance at 800 nm, a deconvolution must be performed to determine the cross-section with 





method, the fluorescence intensity in the range of 450 – 550 nm can be utilized (Figure 2.4A), as this 
fluorescence is purely two-photon in origin.14,53 Although Au25(Capt)18 has a strong infrared emission, 
this emission is also one-photon when excited with 800 nm light, attributed to intraband excitation, as 
discussed by Yi et. al.54 Figure 2.4B shows the log-log power dependence of the PAAm-Au25(Capt)18 
clusters at the 510 nm emission peak. The log-log power dependence of PAAm-Au25(Capt)18 clusters has 
an averaged slope of 2.05 ± 0.035, indicating a fluorescence originating from purely two-photon 








Figure 2.5 A.) Two-photon fluorescence from PAAm-Au25(Capt)18 from 800 nm pulsed excitation. B.) Two-
photon log[Fluorescence]-log[Power] plot from PAAm-Au25(Capt)18 at 510 nm emission. The two-photon 
cross-section derived from the y-intercept was averaged over 3 experiments. 
Using the TPEF method, a large y-intercept means the two-photon cross-section is large.40 Thus, 
the y-intercept of 3.3 (Figure 2.4B) indicates that substantial two-photon absorption is taking place. All 
trials of the power-dependent two-photon fluorescence via TPEF were provided in the Supplementary 
Materials for Au25(Capt)18 and PAAM-Au25(Capt)18 (McLean, Kopelman et. al.). Using the TPEF method, 
the cross-section obtained (“action cross-section”) is a product of the fluorescence quantum yield 
(visible regime) and the two-photon absorbance cross-section. We determine the action two-photon 






respectively (Table 1). Due to the ultra-low quantum yield of Au25 clusters in the visible regime, the 
quantum yield cannot be directly measured, and an absolute two-photon cross-section can only be 
determined by ultrafast techniques,16 or by taking the ratio of the TPEF cross-section to the action cross-
section from the Z-scan method.26 The deconvoluted two-photon cross-section of Au25Capt18 clusters 
has recently been reported via Z-scan by Olesik-Banska et. al. to be 830 GM,52 suggesting the quantum 
yield of Au25Capt18 clusters is about 2 x 10-5. This quantum yield is reasonable when compared to 
quantum yield values (~10-7) of other Au25 clusters determined in the literature, as captopril clusters are 
more fluorescent.14,24,55 
Singlet oxygen efficiency was determined for both Au25 and PAAm-Au25 using singlet oxygen 
sensor green (SOSG) with Rose Bengal (RB) as a standard (Figure 2.5). TMPYP, a common two-photon 
photosensitizer with a cross-section of 116 GM56, was also tested to compare to Au25 and PAAm-Au25 
embedded clusters. 
Figure 2.6 A.) Normalized SOSG fluorescence intensity (Ft/F0), 0 to 40 minutes after continuous Rose 
Bengal (RB), TMPYP, Au25Capt18, and PAAm-Au25Capt18 excitation at identical optical densities. Au25Capt18 
and PAAm-Au25Capt18 points nearly coincide. B.) Ratio of SOSG fluorescence intensity (40 min/0 min) from 







We determine that the singlet oxygen efficiency of TMPyP, Au25Capt18, and Au25Capt18-PAAm is 
18.2%, 1.6%, and 1.4%, respectively. A summary of the two-photon cross-sections and singlet oxygen 
efficiencies of TMPYP, Au25, and PAAm-Au25 is provided in Table 2.1.  
 
Table 2.1 Two-photon absorption cross-section and singlet oxygen quantum efficiency (σO2) of TMPYP, 
Au25Capt18, and PAAm-Au25Capt18.a 
Compound Two-photon absorption cross-section (GM) Singlet oxygen efficiency (%) 
TMPYP 116 ± 21 (ref 56) 18.2 
Au25Capt18 830 (ref 52), 3.85 x 10-2 ± 1.35 x 10-2 (δn) 1.6 
PAAm-Au25Capt18 4.97 x 10-2 ± 2.20 x 10-2 (δn) 1.4 
aFor Au25(Capt)18 and PAAm-Au25(Capt)18 the two-photon absorption is a product of the two-photon 
cross section and quantum yield due to the TPEF method used (δn). 
 
The high singlet oxygen efficiency of RB (75%) and TMPYP (18.2%) are due to their long aqueous 
phosphorescent lifetimes (150 ms and 0.2 ms).57,58 On the other hand, the excited state lifetime of Au25 
has been measured on the order of microseconds.59-61 While TMPYP has a significantly higher singlet 
oxygen quantum efficiency than Au25 (18x), Au25 has a two-photon cross-section that is 8x higher than 
TMPYP. Due to the non-linear nature of two-photon absorption, as the power is increased, significantly 
more photons will be absorbed, drastically improving two-photon PDT efficacy. Furthermore, synthetic 
strategies to increase the singlet oxygen efficiency of an Au25 photosensitizer should be explored in the 
future, for example, through charge-transfer to another chromophore.61,62 Lastly, Au25 has another 
functionality as an X-ray (CT) contrast agent, a theranostic functionality that TMPYP, and organic 






2.4.3 Dark biocompatibility of Au25 and PAAm-Au25 embedded nanoparticles and their in vitro loading 
efficiencies.                                                                                   
To provide evidence for therapeutic PDT usefulness, it is important to ensure that therapeutic 
agents do not cause significant stress to the cells without illumination. The dark biocompatibility of Au25 
clusters is still open to question in the literature, with varying results.28, 63-67 We tested the viability of 
HeLa 229 cancer cells in the presence of 0.1 mg/mL through 10 mg/mL Au25Capt18 clusters incubated in 
the dark under 24 hour incubation. Even at 0.1 mg/mL, we found that cells have approximately 50% 
viability. At 2 mg/mL, less than 5% of cells are viable. On the other hand, PAAm-Au25 particles have 
greater than 85% viability at concentrations as high as 10 mg/mL NP, as shown in Figure 2.6B. We did 
not provide toxicity experiments for Au NCs stored in daylight, but this is an important precaution to 
take when handling the NC. In fact, Kauffmann et. al. show that storing Au NCs under light will produce 
O2 mediated chemistry, however storing Au NCs under dark conditions will not lead to chemistry 
between Au25 and O2.68  
Overall, when comparing biocompatibility of PAAm-Au25 and non-encapsulated Au25 at equal 
effective masses of Au (5% loading), PAAm-encapsulated clusters provide a clear and substantial 
enhancement to viability, as shown in Figure 2.6C. The increased biocompatibility of PAAm-Au25Capt18 






Figure 2.7 A.) Cell viability under dark incubation with Au25Capt18 clusters, from 0.1 – 10 mg/mL, B.) Cell 
viability under dark incubation with PAAm-Au25Capt18 NPs from 0.1 – 10 mg/mL, C.) Cell viability 
comparison of Au25Capt18 cluster and PAAm-Au25Capt18 NPs at equivalent Au25Capt18 dark incubation 
masses, D.) Mass of Au25Capt18 detected via ICP in cells for Au25 and PAAm-Au25Capt18 with Au25Capt18 
cluster incubation masses of 6.25 – 100 ug in 1 mL of media. 
Due to reports that Au25 can have low cell uptake of Au25 clusters,30 we compared the cell 
uptake of Au25Capt18 clusters and PAAm-Au25 via inductively-coupled plasma mass spectrometry (ICP-
MS). Overall, we find that PAAm-Au25 particles have higher in vitro loading (10.6 ± 3.5%) per effective 








manuscript, this increase can be further accentuated for particular tumor types, as PAAm particles have 
been shown capable of conjugation with cell surface targeting moieties to enhance uptake.69,70 
2.4.4 Non-linear Optical PDT Efficacy.  
For an accurate evaluation of non-linear optical PDT effects, cells were illuminated using 800 nm 
pulsed light at 100 mW/cm2 over 15 minute (Figure 2.7) and 5 minute excitations (Figure 2.8). The 
illumination time and power were chosen based on comparable excitation times and powers from the 
previous two-photon in vitro PDT literature.71-73 Calcein AM, a fluorescent dye that marks cell viability, and 
frequently employed to study two-photon PDT, was added to all cells.71,74-76 The Calcein AM signal will be 
diminished as cell membranes rupture or their metabolism is affected, and can be used in conjunction 






























Figure 2.8 PDT images of HeLa cells with control (no NP), 0.5 mg/mL, 1.0 mg/mL and 3.0 mg/mL incubated 
PAAm-Au25Capt/cm2 under 800 nm one-photon (non-pulsed) and two-photon illumination (pulsed), 15 
minute excitation at 100 mW/cm2 (average power). Samples were co-stained with Calcein AM and 
Propidium Iodide (PI) to mark cell viability. Scale bar is 20 μm. 
Control HeLa cells, before and after laser illumination, showed no Calcein AM fluorescence change 
and no PI fluorescence, i.e., no statistically significant cell death after 30 minutes of excitation. Similarly, 
































PAAm-Au25Capt18 incubated cells excited with one-photon excitation show no evidence of PDT-mediated 
cell death 30 minutes after excitation. However, HeLa cells excited under two-photon illumination at 800 
nm with 1.0 mg/mL and 3.0 mg/mL incubated PAAm-Au25Capt18 show remarkable cell death efficacy: 30 
minutes after excitation, >99% of cells in the region are dead, as indicated by the loss of Calcein AM 
fluorescence and the presence of PI fluorescence. The cell death observed in the presence of NPs and light 
must most probably be PDT mediated. While we cannot exclude the possibility that part of the cell kill 
effect was via two-photon photo-thermal therapy (PTT), PTT has been shown to cause Au25-mediated cell 
death only at powers above 7.5 W/cm2 (4 minute) and with high effective Au concentrations (0.75 
mg/mL).77 In contrast, by here only using 100 mW/cm2 excitation and a maximum effective Au25 
concentration of 0.15 mg/mL, the conditions to induce PTT were not met in this study. To summarize, 
with one-photon excitation, only <1% of the cells show PDT-mediated cell death, as propidium iodide 
indicates. In contrast, under two-photon excitation, >99% of cells show such PDT-mediated cell death. 
These results point to the substantial benefits of using two-photon PDT. 
We also evaluated two-photon photodynamic therapy using 5 minute excitation at 800 nm, with 
100 mW/cm2 (Figure 2.8). Overall, PAAm-Au25 concentration-dependent cell death was similar to the 15 























Figure 2.9 PDT images of HeLa cells with control (no NP), 0.5 mg/mL, 1.0 mg/mL and 3.0 mg/mL incubated 
PAAm-Au25Capt/cm2 under 800 nm one-photon (non-pulsed) and two-photon (pulsed) illumination, 5 
minute excitation at 100 mW/cm2 (average power). Samples were co-stained with Calcein AM and 
Propidium Iodide to mark cell viability. Scale bar is 10 μm. 
We note that the same NPs could also serve as a contrast agent for CT of soft tumors, as gold 
compounds do enhance scattering by X-rays, with ample literature examples.78,79 For future in-vivo 
research, targeted PAAm-Au25Capt18 gold cluster-based nanoparticles should be investigated for 


































 In summary, our work produces and characterizes the PAAm-Au25(Captopril)18 nanocluster and 
its embedded hydrogel nanoparticles, utilizing them for two-photon photodynamic therapy applications. 
These PAAm-Au25 NPs also show (1) highly enhanced cell biocompatibility and (2) greater cell uptake, 
compared to the unembedded cluster. Furthermore, we have demonstrated highly efficacious in vitro 
two-photon PDT using those PAAm-Au25Capt18 NPs, demonstrating a tremendous enhancement in this 
2p-PDT-mediated cell death over one-photon PDT. We associate this enhancement with the high non-
linear cross-sections of the Au25 clusters. This new 2-photon photodynamic agent, the Au25 cluster, (a) 
has a two-photon cross-section 8x bigger compared to TMPYP, a highly used two-photon 
photosensitizer, (b) has an activity rising quadratically with increased photon power, (c) offers the 
opportunity for improvement with chemical synthesis stratagems and (d) is also a potential theranostic 
agent enabling improved CT imaging. Furthermore, when embedded in hydrogel NPs it gives both better 
biocompatibility and potential tumor targeting. 
In future research, one goal should be to improve the reactive oxygen production efficiency of the 
Au25 clusters, possibly via charge-transfer to an acceptor chromophore, as well as to explore targeted 
PAAm-Au25Capt18 for dual 2p-PDT and CT theranostic applications. Overall, due to their high non-linear 
cross-sections, Au25 clusters, especially with encapsulation in PAAm NPs, present an attractive 
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Chapter 3: Gold Nanosnakes: Controlled Synthesis of Linear Nanochains with Tunable Plasmon 
Resonance for Nano-Biophotonics 
3.1 Abstract 
The development of plasmonic nanomaterials with controlled linearization and optical tunability 
is of wide interest in biophotonics and nanomedicine, provided they are biocompatible. Highly linear gold 
nanochains, “gold nanosnakes”, were prepared by a controlled synthesis scheme, starting from ultrapure 
gold nanosphere monomers, having a bare (virgin) surface. They exhibit 1-2 nm tunable longitudinal 
surface plasmon resonance (LSPR) over the range from 590 to 640 nm. To determine the ensemble 
statistics of the nanosnake lengths and their branching, transmission electron microscopy (TEM) images 
were acquired, in batch, correlated with the nanosnake longitudinal SPR maxima (590 to 640 nm). Utilizing 
the distributions from TEM image analysis, discrete dipole approximation computations reproduce the 
experimental UV-Vis spectra, confirming sample integrity. In vitro dark-field microscopy, and 
biocompatibility measurements, demonstrate the nanosnakes’ (1) enhanced scattering cross-sections 
related to the plasmon coupling between the constituent nanospheres, (2) highly accessible surface 
enabling facile conjugating with cell targeting ligands, and (3) absence of cell toxicity. Monte-Carlo 
simulations quantify the selectivity of the chemical reaction: chain-end gold nanosphere units are 3-4 
times more reactive than chain-center units. The synthesized, highly-linear, spectrally tunable gold 
nanosnakes represent a new and biocompatible nanosystem, which could be utilized in photonic, 







Colloidal gold nanoparticles (Au NPs) have been intensively studied and utilized over a broad 
range of biomedical fields, such as imaging1–4, chemical sensing5–7, diagnostics1,8, and cancer/disease 
therapies8–13. Au NP colloids display unique size-, morphology-, and composition-dependent optical 
properties not observed from their bulk or molecular counterparts (e.g. nanoclusters) that produce their 
utility.14–16 These new properties have been attributed to a longitudinal surface plasmon resonance (LSPR) 
that arises from collective oscillations of the conducting electrons in the valence band.17,18 A colloidal 
solution of Au NP monomers can be produced in large quantities, via chemical (synthetic) approaches.19 
Alternatively they can be produced by physical methods, like the one used in the present study: pulsed 
laser ablation (PLA).17,20 However, the scalable production of dimer, trimer, and higher order nanochains 
(tetramers, pentamers, etc.) is still exploratory. Overall, colloidal gold nanochains can have many 
advantages as a new nanomaterial. For example, these gold nanochains, when linear, exhibit significantly 
red-shifted absorption spectra, thus allowing imaging at redder wavelengths, i.e. within the biological 
window of optical absorbance and lower light scattering.21 In addition, gold nanochains have been shown 
to have enhanced scattering cross-sections, thus an increased potential for SERS (surface enhanced 
Raman spectroscopy), due to the existence of plasmonic hot spots inside the gaps of the NPs within the 
chain.22,23  
 The step-growth synthesis of colloidal gold nanochains has been documented in the past.24–26 
Several methods have been used to fabricate such nanosystems, including template-based methods 
(lithography, shell-driven aggregation) and template-free methods, and different types of monomers have 
been utilized, like Au nanospheres and Au nanorods. Template-based methods, for example lithographic 
arrays, or polydimethylsiloxane (PDMS) substrates, can be used to synthesize plasmonic nanomaterials 
(chains, globular clusters), but require extensive fabrication and specialized molds.27–29 Thus, while 





scalability are major limitations on the use of such lithographic (i.e. electron beam, ion beam) 
techniques.30 Utilizing PDMS molds is a promising new, cheaper technology for fabricating nanochains and 
nanoglobules; however, controlling gap distances, dispersity, and plasmonic tunability, in addition to 
scalability, remain as challenges.28,29 Alternatively, polymeric shells and chiral small molecule-conjugated 
micelles (‘surface template’ nanochemistry) have been used to encapsulate Au NPs so as to create 
polydisperse linear nanochains; however shell formation is irreversible and biotoxicity remains an issue, 
with its severity depending on the polymers used.31–33 Template-free methods have also been used to 
synthesize nanochains, but most require ethanol and typically occur over short timescales (<30 min). 
However, long timescales are desired so as to better control nanochain formation.21,26,34,35 More 
specifically, inducing nanochain assembly over long timescales has two advantages: 1.) Synthesizing highly 
precise LSPR nanomaterials is more easily achievable using longer time scales, because the quenching-
time is less prone to error, 2.) Longer timescales are typically required so as to produce highly linear 
chains.26,36 For example, Yang et. al. demonstrated that when polymer-assisted nanochain aggregation 
occurred over long timescales (8 hours), samples were highly linear and the spectral band (LSPR shift) was 
sharp and pronounced.26 However, over fast timescales, globular products formed with a wide spectral 
band-width.26 Most aqueous-based techniques, such as Au NP-aptamer aggregate synthesis, have been 
useful in producing globular clusters, but the production of highly anisotropic, linear clusters has remained 
a challenge.37,38 Notably, Au nanospheres, rather than Au nanorods, are utilized for chain formation in the 
present study. Au nanorods may have been the most studied material for their optical property of a 
tunable plasmonic resonance.39 However, Au nanorods have intrinsic disadvantages as a biomedical 
material, including the cetyltrimethylammonium bromide (CTAB) conjugation that makes the nanorods 
toxic.40–42 Also, the ligand-exchange methods that are required for modifying the nanorod surface do 
hinder greatly both ease-of-fabrication and scalability.42 For example, so as to conjugate nanorods with 





by Wan et. al.42 Also, in contrast to elongated Au nanorods, the here assembled Au nanosphere chains, 
with their nano-gaps (between nanospheres), provide highly intense electric field hotspots, and such 
intense fields are of interest to many applications, such as imaging and microscopy.43,44 
In the present study, we report a facile method for large-scale fabrication of highly linear and 
biocompatible gold nanochains suspended in aqueous solution with controllable length and short 
interparticle gap distance (<2 nm). These highly linear gold nanochains are named “gold nanosnakes” in 
the rest of this paper. They are synthesized via first producing 20 nm Au NP monomers having virgin 
surfaces, using the pulsed-laser ablation (PLA) method, as shown in Figure 3.1-1. The PLA method was 
chosen here because compared to other, typically chemical, methods it is a complete green synthesis 
(fulfilling all 12 principles of green chemistry).45,46 Thus we produce nontoxic, stable, and high-purity Au 
NP monomers in deionized (DI) water. To perform the PLA method, a high-power, femtosecond pulsed 
laser ablates the pure bulk Au metal in DI water (Figure 3.1-1), and the Au NPs are formed in the same DI 
water, thus not requiring precursor, reductant, stabilizing or capping agents. Hence this method does not 
introduce any chemical toxicity or biological hazards; it is thus a low environmentally impacting technique. 
Furthermore, these PLA-generated AuNP monomers, with their bare (virgin) surfaces, provide unique 
surface properties. For example, in our previous studies we have demonstrated that the bare (virgin) 
surface ensures facile, rapid (1-2 hours), and highly controllable conjugation of ligands, such as methoxy 
polyethylene glycol (mPEG), with a tunable surface coverage between 0 to 100%.47,48 Also, efficient 
peptide and small molecule conjugation has been demonstrated on PLA-produced Au monomers with 
high molar ratios (on the scale of thousands of peptides per gold NP).49,50 As such, PLA-produced Au 
nanospheres, with their virgin surfaces, may be the best starting material for nanochain development 
involving highly controlled surfaces. 
 After the fabrication of the Au NP monomers, the self-assembly of colloidal Au NPs into 





of ligands: pentapeptide with an amino acid sequence CALNN and cysteamine (Figure 3.1-2). This was 
done in a sequential manner by first mixing the colloidal Au NPs with CALNN and then with cysteamine. 
The binding to the NPs of the CALNN peptides and the cysteamine is possible due to the strong anchoring 
of the gold-sulfur bonds, which covalently attach two ligands to the surface of the Au NPs. The CALNN 
peptides were bound onto the NPs because they are well-known ligands for improving NP colloidal 
stability.51 The latter is critical so as to achieve a proper balance between the repulsive and attractive 
forces after addition of the cysteamine molecules, which is a governing factor in linker-mediated assembly 
of NPs.52 The cysteamine molecules were coated onto the nanoparticles because they contain two 
reactive terminal groups, sulfhydryl (-SH) and amine (-NH2), which can link or bridge Au NPs via attaching 
to their surface by either covalent bonds (-SH groups) or by electrostatic attraction (-NH2), thereby 
forming nanosnakes within 24 – 72 hours, depending on the desired longitudinal SPR shift (Figure 3.1-3). 
It is worth noting that only the minimal amount of CALNN peptides and cysteamine molecules necessary 
for inducing nanosnakes formation is used for the surface modification of the Au NPs. In this way, enough 
space is left on the surfaces of the gold nanosnakes for subsequent conjugation of biomolecules, such as 
targeting ligands necessary for use in various biomedical applications. Notably, utilizing UV-Vis 
spectroscopy to ‘monitor’ chain assembly, the growth of the nanochains can be quenched at will by adding 






























Figure 3.1 Summary of nanosnake formation. Step 1. Au nanoparticle monomers of 20 nm in diameter, 
having virgin surfaces, are produced by pulsed laser ablation. Step 2. Surfaces of monomers are modified 
with CALNN peptide (blue; 2400:1) and cysteamine (red; 1800:1). Step 3. Self-assembly of monomers into 
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nanosnakes after surface modification. The ensemble of nanosnakes with longitudinal surface plasmon 
resonance (LSPR) mode at 620 nm is shown as an example. Step 4. Nanosnake growth is controlled by UV-
Vis monitoring and quenching at a desired LSPR, using thiol terminated methoxy polyethylene glycol 
(mPEG-SH) with molecular weight of 5000 Da. The gold nanosnake samples synthesized are labeled in the 
photograph insert [A, gold monomer with SPR at about 525 nm; B-F nanosnake samples with LSPR at 590 
nm (B), 610 nm (C), 620 nm (D), 630 nm (E), and at 640 nm (F)]. 
Overall, the advantages of our technique are:  
1.) Starting from 20 nm Au NP monomers produced by the PLA method with a virgin surface 
(homogenous and ultrapure) allows for their controlled self-assembly on a large scale. As 
mentioned earlier, the surface conjugation is facile, rapid (1-2 hours), non-toxic, and highly 
controlled (ligand ratios for surface conjugation between 0-100% can be precisely controlled). 
Currently, the batch volume of nanosnake synthesis with optical density (OD) 1, at the tunable 
LSPR, is 1 liter.  
2.) The self-assembly of nanosnakes (from Au monomers) can be spectrally monitored and tuned, 
wherein rapid quenching can be used to select for the desired plasmonic wavelength, with a 
spectral resolution precision of about a couple of nanometers (1-2 nm). 
3.) Unlike other anisotropic gold nanosystems, i.e. assembled nanorods which suffer from high 
toxicity and challenging conjugation paradigms40–42, the Au nanosnake synthesis does not 
involve toxic intermediates and, in addition, the surface conjugation with peptides or small 
molecules is facile.  
4.) The Au nanosnakes have intense electric field hotspots in the gaps between monomers, of 
immense potential utility for a variety of imaging and microscopy applications. 
5.) The synthesis is performed in aqueous environments (DI water) and samples can thus be used 





Using the above method, we have synthesized five samples of highly linear gold nanosnakes exhibiting 
red-shifted longitudinal SPR from 590 nm to 640 nm, and verified their linearity by transmission electron 
microscopy (TEM). In addition, Monte-Carlo simulations of nanosnake formation from Au NP monomers 
have been performed, which provide an interesting insight into the selectivity of the synthesis, revealing 
that the center units of nanosnakes are about 3-4 times less reactive than their end units, thus preventing 
chain branching and thus driving the growth of highly linear nanosnakes, rather than nanoglobules. 
Furthermore, by coupling the theoretical results of DDA (discrete dipole approximation), calculations of 
the extinction spectra for each linear oligomer (monomer, dimer, trimer, etc.) with the weighted 
experimental nanosnake length distribution obtained from TEM image analysis, we can reproduce the 
optical extinction spectra for all experimental samples, thus confirming sample integrity. Moreover, we 
have confirmed the enhanced scattering cross sections of the nanosnakes revealed from our DDA 
calculations (enhanced by approximately 3x when normalized to the number of AuNP monomers 
constituting the nanosnakes) via comparing the brightness of the nanosnakes to that of the AuNP 
monomers, observed in vitro by dark-field light scattering microscopy.  Lastly, the in-vitro (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assay (MTT) demonstrates 
the gold nanosnakes’ little or no cytotoxicity at a mass concentration as high as 0.25 mg/mL. Therefore, 
the synthesized gold nanosnakes have several highly desirable properties for a wide range of potential 
biomedical applications, such as enhanced in vitro and in vivo contrast imaging, diagnostics, and targeted 
theranostics. 
 
3.3 Experimental Procedures  
3.3.1 Materials and Instrumentation  
All chemicals were used as received without further purification. mPEG-SH with a molar mass of 
5000 g mol−1 (mPEG 5k-SH) was purchased from Creative PEGWorks (Chapel Hill, NC). Both cysteine-





RGDRGDRGDRGDPGC and pentapeptide ligand with an amino acid sequence CALNN having purity higher 
than 95% were custom-synthesized by RS synthesis LLC (Louisville, KY). Cysteamine (CAS Number: 60-23-
1) with purity higher than 95% was purchased from Sigma-Aldrich. PEG, peptides, and cysteamine were 
in powder form and dissolved in DI (de-ionized) water having an electric conductivity less than 0.7 μS cm−1. 
All solutions were freshly made as needed and used within twelve hours. UV–Vis absorption spectra were 
recorded by a spectrophotometer (UV-3600, Shimadzu Corp., Japan). 
3.3.2 Production of the colloidal Au NPs 
We first produced primary spherical colloidal Au NPs having virgin surfaces, to be used for the 
fabrication of gold nanosnakes via a physical method of femtosecond PLA of a bulk Au target (Purity: 
99.99%) immersed in DI water, as described in our previous publication.47 This method uses tightly focused 
micro-joule (μJ) femtosecond laser pulses to produce NPs and the size/size distribution of the generated 
NPs can be precisely controlled by optimizing the laser parameters, such as wavelength, pulse energy, 
duration, and repetition rate.47 
Briefly, the ytterbium-doped femtosecond fiber laser (FCPA μJewel D-1000, IMRA America, Ann 
Arbor, MI), operating at 1.045 μm, delivered laser pulses at a repetition rate of 100 kHz, with 10 μJ pulse 
energy and 700 fs pulse duration. The emitted laser beam was first focused by an objective lens and then 
reflected by a scanning mirror to the surface of the bulk gold target, which was submerged in flowing de-
ionized water (18 MΩcm). The size of the laser spot on the gold target was estimated to be 50 μm and its 
position was precisely controlled by the scanning mirror. Colloidal Au NPs with an average diameter of 20 
nm were produced by this PLA method and used in our experiments. The generated nanoparticles have a 
narrow size distribution and have an absorption peak at 520 nm due to the localized surface plasmon 
resonance.38 
It is worth mentioning that during the PLA, the generated Au NPs are partially oxidized by oxygen 





surface of Au-O-.53 Therefore, the Au NPs produced using the PLA method are naturally negatively charged 
and no capping agents or stabilizing ligands are required for maintaining their colloidal stability. This 
unique feature of having a virgin surface because of a capping-agent free procedure does allow versatile 
surface modifications for obtaining Au NPs with controllable surface chemistry,47 which is utilized in the 
present study to assemble them into spectrally tunable gold nanosnakes. 
3.3.3 Characterization of Au Nanoparticle Surface Coverage 
To characterize the surface coverage of the Au nanoparticles, dynamic light scattering (DLS) was 
used to measure the increase in the Au NP radius after the small molecule (i.e. peptide) coverage. Dynamic 
light scattering has been used before to study surface conjugation of Au NPs by peptides.54,55 In brief, the 
hydrodynamic diameter of the peptide-modified (CALNN peptide in this study) gold nanoparticle 
monomer nanospheres (20 nm), which includes the nanoparticle surface coating and the hydrated water 
ions, is measured (Malvern Nano Zetasizer ZS90 DLS). The Malvern Nano Zetasizer DLS is equipped with a 
633 nm He–Ne laser and an avalanche photodiode serves for detecting the scattered light at a 90-degree 
angle. In a standard measurement made in the automated mode, the instrument selected the attenuation 
factor and then recorded between 12 and 16 runs, measuring the dynamic light scattering (DLS) of the 
nanoparticles, which is determined by their Brownian motion, for calculating the intensity-average 
diameter. Three successive DLS measurements were performed for each sample and the mean diameter 
increase was reported with the error bar corresponding to the standard deviation over these three 
measurements. As shown in Figure 3.2, a 20,000:1 molar peptide ratio is required for surface saturation, 
indicating that the CALNN (2400:1), cysteamine (1800:1), and peg (200:1) molar ratios used in this study 






Figure 3.2 Increased diameter (nm) of 20 nm Au monomers after CALNN peptide conjugation at various 
CALNN molar conjugation ratios (200:1-40000:1) determined through dynamic light scattering (DLS). 
3.3.4 Self-assembly of Au NPs into Nanosnakes  
In a typical process, colloidal Au NPs with an average diameter of 20 nm (STD 3 nm) and a zeta 
potential of -40 mV were mixed with a pH 7.0 aqueous solution of CALNN peptides, so as to achieve a 
defined molar ratio of 2400:1 between the CALNN peptides and the Au NPs. The mixture of Au NPs and 
CALNN peptides was kept undisturbed for 2 hrs at room temperature so as to enable sufficient 
conjugation of CALNN peptides to the Au NPs via gold-sulfur bonds. Following the surface conjugation of 
the CALNN peptide, the Au NPs were further modified with cysteamine molecules, by mixing with the 
cysteamine solution, so as to achieve a molar ratio of 1800:1 between the cysteamine molecules and the 
Au NPs. The solution was kept undisturbed until observing a significant color change, from red-pink to 
blue, which typically occurs between 24 hours to 72 hours after addition of cysteamine and serves as clear 
evidence for a successful self-assembly of NPs into nanosnakes.  



























Furthermore, gold nanosnakes with controllable lengths and tunable LSPR were fabricated by 
quenching the growth of the nanosnakes via binding mPEG 5k-SH molecules onto them after their LSPR 
reaches a desired wavelength. This was done by adding a solution of mPEG 5k-SH so as to achieve a molar 
ratio of 200:1 between the mPEG 5k-SH molecules and the Au NPs. The PEG molecules can stop the growth 
of the nanosnakes because they introduce steric repulsions between the Au NPs. Notably, PEG with 
molecular weight of 5000 Da specifically has been used by other groups (i.e. Scott et. al.) in biological 
nanosystems so as to reduce adsorption.56  In the present study a total of five distinct samples of gold 
nanosnakes were produced, with the LSPR ranging from 590 nm to 640 nm.   
In our search of the CALNN and cysteamine ratios to be used for fabricating the gold nanosnakes, 
our principle for determining the appropriate ratio was to choose the minimal amounts of CALNN and 
cysteamine necessary for inducing the self-assembly of Au NP monomers into stable nanosnakes. By 
minimizing the molar ratio of each component, there remains enough empty space on the surface of the 
nanosnakes for subsequent conjugation of other functional ligands. Based on this principle, we found the 
ratios of 2400:1 and 1800:1 to be the best ratios, respectively, for the CALNN/Au NP and cysteamine/Au 
NP conjugations. Furthermore, in terms of pH stability, Jia. et. al. showed that CALNN conjugated Au NPs 
have stable aggregation properties for pH<9.57 For cysteamine, within the range of pH 4-10, Au-
cysteamine aggregates have been shown to be stable, with pH>10 resulting in the deprotonation of the 
sulfur moiety, leading to destabilization of the product.58,59  Notably, our in vitro experiments were 
performed at pH = 7.4, under stable pH conditions. 
3.3.5 Transmission Electron Microscopy (TEM) and Image Analysis 
Nanosnake samples were deposited on TED Pella (trade name) 200 Cu mesh grids (Lot#: 160419).  
To determine the mass distributions of the Au nanosnakes, TEM imaging was performed at 80 kV on a 
JOEL JEM 1400 transmission electron microscope. For every sample, 3 grids were analyzed with over 50 





cropped via ImageJ from the raw images. Following cropping, so as to identify the number of monomers 
in each nanoparticle, the images were analyzed using the CellProfiler program.60 In brief, CellProfiler can 
identify objects using an intensity threshold (lowest accepted pixel intensity compared to max intensity) 
and the shape of the object (circular), and has been shown to be a useful tool to conduct quality control 
for properties like the size and shape of nanoparticles and nanoparticle aggregates.61 For this study, 
thresholds of 60, 70, and 80% were tested for identifying individual monomer shapes. As the sample 
images show in Figure 3.3, the CellProfiler output identifies individual monomers from their circular 
outline (the monomers identified are given separate colors). After identification, the number of counted 
monomers within a nanosnake are summed together to determine the total number of monomers per 
nanosnake. Due to the intensity variation between samples, the highest count was selected among 60, 






Figure 3.3 Nanosnakes processed through CellProfiler. For each nanosnake pair, the A.) original image (no 
scale bar) is B.) inverted, and then C.) processed through CellProfiler, where each unique color is an 
identified counted monomer.  
High resolution TEM microscopy was utilized to determine the gap distance (spacing) between 
monomers in the Au nanosnakes. The high resolution microscopy was performed on a JEOL JEM 2100F 





0.5 nm, using highest (2500000x) and lowest (250000x) magnifications. After acquiring high resolution 
TEM images, the gap distances were analyzed using ImageJ ‘measure’ tool on raw (unadjusted) intensity 
data by importing image data with the NIH developed DM3 Reader Plugin 
(https://imagej.nih.gov/ij/plugins/DM3_Reader.html). Note that to preserve image fidelity, DM3 images 
were utilized for gap distance determination, instead of converting images to a compressed format. For 
each gap distance, measurements were collected three times and averaged to determine the error 
(standard deviation reported). 
3.3.6 Monte Carlo (MC) Simulations 
A number of NPs (monomers), equal to the total number of NPs for each experiment, are 
randomly placed on a cubic lattice with fixed concentration (c = 10-3 for the 3-dimensional lattice). The 
monomers are considered to be clusters of size s = 1. Diffusion of the clusters starts by randomly choosing 
a cluster and allowing it to move to a neighboring position, which consumes one microstep. The diffusion 
constant is considered to be inversely proportional to m, the mass.62–64 Thus a random number x ∈ (0,1) 
is chosen and if x < 1/m the cluster diffuses by moving one cell length in a random direction to a 
neighboring site (or sites) on the lattice, assuming they are not already occupied by the NPs of another 
cluster (excluded volume condition). If two or more clusters contact each other (i.e. there are monomers 
at neighboring sites), they merge into one cluster with a (sticking) probability that depends on the position 
of the contacting NPs in the cluster. The ratio of the sticking probabilities of end vs. center particles was 
tested at 0.01, 0.1, 0.2, 0.3, 0.5, and 1.0. Thus, we have p = 1 if the contacting monomers of both clusters 
are at the end of their cluster and p = 0.01-1.0 otherwise. For each monomer we keep track of the number 
n of neighboring monomers to which it is connected. Thus, a lone monomer (cluster of size s = 1) has n = 
0, the monomers of a cluster with size s = 2 both have n = 1, a linear cluster with size s = 3 has two 





n = 0 or n = 1 are considered to be at the end of the cluster. Other monomers in a cluster with n > 1 are 
“central”. Sticking to them has the adjusted probability provided above (0.01-1.0). 
The time after each step is increased by Δt = 1/N (one MC microstep), where N is the number of 
clusters remaining, regardless of whether the cluster moved or not.65–67 Clusters of increasing size s are 
formed as the simulation proceeds and the simulation stops when the number N of the remaining clusters 
becomes equal to the number of clusters in the target experimental sample. Whenever two objects 
(particles or clusters) are merged into one, they are combined irreversibly and the number of neighbors 
of the contacting monomers is increased by 1, with periodic boundary conditions utilized. Monte Carlo 
simulations are run 100 times per sample, and the cluster distributions are averaged.   
3.3.7 Discrete Dipole Approximation (DDA) Calculations 
Discrete dipole calculations were performed using DDSCAT (“Discrete Dipole Scattering”) version 
7.3.2 to compute the optical extinction coefficient, absorbance, and scattering spectra of linear clusters 
of Au NPs in an aqueous medium (n = 1.33). Reviews of the discrete dipole approximation technique and 
DDSCAT have been provided by previous authors.68,69 To run DDSCAT, several user inputs are required: 1.) 
The complex polarizability of Au, 2.) The geometry of the Au NP clusters, and 3.) The Effective radius of 
the Au NP snakes (See Equation 3.1). The complex polarizability (function of wavelength from 300-800 
nm) of Au was utilized from Johnson et. al.70 To generate the geometry of the Au NP clusters, we wrote a 
Python code that specifies the monomer radius, the length of linear clusters of Au NPs, and the 
interparticle gap distance, so as to generate input files. The following code is posted to GitHub in a public 
repository at: https://github.com/KopelmanLab. Lastly, the effective radius is computed by,  
                                                                             reff = (n(rmonomer)3)1/3                                                                    (3.1) 
Here reff is the effective radius, n is the length (number of units) of the linear clusters, and rmonomer is the 





Of particular importance for the discrete dipole computations is the number of dipoles-per-
nanometer (dpnm) in the input geometry.71,72 Previous studies have found that above a 1 dpnm resolution 
for nanosized objects, the generated spectra are minimally affected by dpnm increases.72 Hence, within 
the main body of this paper, all spectra are generated from 1 dpnm geometries. 
  Following the DDSCAT computations, UV-Vis spectra were generated based on the simulated DDA 
extinction spectra and the experimentally measured mass distributions of the synthesized gold 
nanosnakes. Figure 3.4 shows a summary of the steps required for this process. In brief, a weighted linear 
combination of the DDA-computed spectra for linear clusters of Au NPs was taken with respect to each 
oligomer’s percent frequency from the experimental TEM distribution. For every element (i.e. dimer, 
trimer, etc.) within the computed DDA linear combination set, the incoming light (k-vector) x, y, z 
orientational contribution to the extinction spectra was averaged with equal weight (light is unpolarized 
along each orientation). Furthermore, due to the ‘resolution’ of DDSCAT (using a 1 dpnm computation can 
only yield output for integer spacing), non-integer gap distance extinction spectra were interpolated using 
the 1.00, 2.00, and 3.00 nm computed extinction spectra at each wavelength (350 – 800 nm) from 2nd 








Figure 3.4 Protocol used to compute the optical extinction spectra of the nanochain ensemble. First, the 





excitation (left diagram with example spectrum). Next, ensemble averaging is performed utilizing TEM 
distributions to generate a simulated spectra (red) compared to an experimental spectra (black). 
A mean squared error of the computed optical extinction spectra of the ensemble average was 
determined using gap distances ranging from 0.8 nm to 2.0 nm, with 0.05 nm resolution. The mean 
squared error (MSE) is defined as, 




                                                         (3.2) 
Where ntheoretical is the value of the theoretical point (i.e. simulated ‘y’) at value ‘x’, nsample is the value of 
the sample point (i.e. experimental ‘y’) at the same ‘x’, and n is the total number of theoretical samples 
evaluated in the sum. To generate the electric field data, DDSCAT electric field output (.E format) was 
converted to VTR format and imaged using the Mayavi Python package.73 
3.3.8 Conjugation of RGD Peptides onto Au Nanosnakes  
RGD peptides are well-known to bind preferentially to the αvβ3 integrin proteins, which are 
overexpressed on the surface of most types of cancer cells.74 Therefore, we chose to conjugate them onto 
gold nanosnakes for obtaining cancer cell-targeting conjugates. Within five gold nanosnake samples 
fabricated, the samples with LSPR at 640 nm were selected for this conjugation and the conjugation was 
done by adding 12 uL RGD peptide solution, with a concentration of 1 mM, to a 10 mL sample of gold 
nanosnakes with an optical density (OD) of 1 at 640 nm. The resultant solutions were allowed to stand for 
2 hrs at room temperature, to ensure a sufficient conjugation of the RGD peptides onto the unoccupied 
surfaces of the gold nanosnakes. The final solution was transferred into a 15 mL centrifugal tube and 
centrifuged at 1000 g for 0.5 hr. After removing the supernatant, the final OD of the RGD peptide-
conjugated colloidal gold nanosnakes was adjusted to 10 by resuspending the NP pellet with a 4 mM 





3.3.9 Human HeLa Cell Culture  
The Human HeLa 229 cell line was selected for our study and was cultured according to the 
following protocol. (1) 6 mL human HeLa 229 cells in the logarithmic growth phase (American Type Culture 
Collection), at a density of 1 X 104 cells/ml, prepared in Dulbecco’s modified Eagle medium (DMEM 11995) 
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin, were first seeded into 
a BD Falcon Primaria tissue culture dish (100 mm x 20 mm) and were cultured aseptically at 37°C and 5% 
CO2 in a humidified incubator; (2) Cells were allowed to grow to at least 70% confluence in a 100 mm x 20 
mm petri dish. At the end of incubation, the culture medium was gently aspirated and then the cells were 
washed twice with 5 ml Dulbecco's Phosphate Buffered Saline (DPBS);  (3) After their careful washing with 
DPBS, the cell culture was passaged, by incubating the cells with a 1 ml 0.05% Trypsin-EDTA solution at 
37°C, until the cells attained a rounded morphology, followed by resuspension of the detached cells, by 
adding 4 ml DMEM supplemented with 10% FBS and 1% penicillin-streptomycin, and centrifugation for 5 
minutes at 500 g; (4) Following the centrifugation, trypsin and DPBS were aspirated and then the cell 
pellets were resuspended, by adding a 3 ml clear cell culture medium of DMEM without 10% FBS; (5) 
Replating a 1 mL suspension of the cells from step 4 into a 35 mm petri dish; then the cells were cultured 
for an additional 24 hours at 37°C and 5% CO2 in a humidified incubator, thus allowing cells to attach to 
the surface of a new petri dish, prior to initiating treatment with the RGD peptide-conjugated gold 
nanosnakes. 
3.3.10 Cellular Incubation with RGD Peptide-conjugated Gold Nanosnakes 
The following procedure was used to incubate Human HeLa 229 cells with RGD peptide-
conjugated gold nanosnakes. (1) A stock solution of RGD-conjugated gold nanosnakes was mixed with 
Dulbecco’s modified Eagle medium (DMEM 11995) without 10% fetal bovine serum (FBS), to achieve a 
new suspension of gold nanosnakes with an OD of 1 at the given LSPR; (2) A 35 mm petri dish containing 
the HeLa cells designated for an imaging test was aspirated of its original culture medium, which was 





Thereafter, a 1 mL suspension of RGD-conjugated gold nanosnakes from step 1 was added to cells and the 
cells were incubated for 12 hours at 37°C and 5% CO2 in a humidified incubator, for allowing cellular 
uptake of the nanosnake conjugates; (4) At the end of incubation, cells were washed with 1 ml 1X PBS 
buffer, three times, to remove free gold nanosnake conjugates in solution;  (5) Cells were fixed onto a 
petri dish by adding 0.5 mL of fresh 4% paraformaldehyde in PBS for 15 min, followed by washing cells 
three times with 1 ml 1x PBS buffer; (6) Finally, 1 mL 1x PBS buffer was added to the petri dish and the 
cells were stored at 4°C before the optical imaging analysis. 
3.3.11 Dark-field Light Scattering Imaging 
The dark-field light scattering images were recorded using an inverted Nikon Epiphot 200 
microscope equipped with an incandescent tungsten-halogen lamp (100 W) as a white light source. In 
order to acquire high-quality images, a high numerical aperture (NA > 0.55) is necessary. Therefore, a 
Nikon long working distance (f = 8 mm) 50x air immersion objective lens, with a numerical aperture of 
0.55, was used to focus the incident light from the tungsten-halogen lamp onto the samples, and also to 
collect only the scattered light from the samples. The dark-field light scattering pictures of the cells were 
captured by using a Nikon digital sight DS-Fi1 camera with an exposure time of 2 seconds. Under this dark-
field light scattering microscope, intense colors of orange should be clearly seen to spread out in the 
human HeLa 229 cells, due to the intense light scattering of the internalized gold nanosnakes with an LSPR 
at 640 nm. 
3.3.12 Cell Toxicity Experiments (MTT) 
 The MTT (3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay is employed as a 
way of measuring whether any stress is placed on the cells by being in the presence of the nanosnakes. 
By use of a 96-well plate, 5000 cells (HeLa, MDA-MB-231, BE(2)-C) were plated onto each well in 100 μL 
of Dulbecco’s Modified Eagle Media pH 7.4 (DMEM). The cells were incubated for 24 hrs, to ensure 
adhesion to the plate. For each cell line, a gold nanosnake sample with LSPR at 640 nm was added to five 





for all wells. A control sample was made for each cell line, without any NP treatment. After an additional 
24 hrs of incubation, 20 μL of a 0.5 mg/mL solution of the MTT dye in PBS was added to each well. After 
3 hrs, the media was removed and replaced with 200 μL of dimethyl sulfoxide (DMSO). The plate was 
transferred to an Anthos 2010 plate reader and scanned at 550 nm excitation. To calculate the viability, 
the raw data for each nanosnake mass concentration were averaged (n = 5), so as to reduce random error. 
The percent viability was normalized by dividing the average values for each nanosnake mass 
concentration by the control average value. Error bars were determined from the compound standard 
deviation of the five trials for each sample. 
3.4 Results and Discussion 
3.4.1 Synthesis and Physical Characterization of Au Nanosnakes 
 Starting from 20 nm Au NP monomers having virgin surfaces, gold nanosnakes were synthesized 
as described in the Experimental Section. These gold nanosnakes display characteristic shifts in their UV-
Vis absorption spectra (Figure 3.5), with a new secondary peak first emerging at approximately 590 nm, 
which can be tuned to 640+ nm, in addition to the fixed primary “monomer” 525 nm peak. The red-shifting 
of the UV-Vis spectra is caused by the nanosnakes’ growth, which occurs over a period of up to 72 hours. 
The nanosnake solution exhibits changes in color over time, with images taken after quenching occurred 
at 2 (B), 5 (C), 10 (D), 27 (E), and 72 (F) hours after nanosnake assembly initialization.  






Figure 3.5 A.) (Top) UV-Vis spectra of Au nanosnakes and (bottom) color images for each sample: 525 nm 
(monomer); 590 – 640 nm LSPR peaks (nanosnakes). B-F.) (Top) Compositive TEM images of gold 
nanosnakes with LSRP peaks ranging from 590 to 640 nm. (Bottom) Nanochain distributions as 





chain-end-unit/chain-center-unit sticking probability is 3.3:1, an optimal value determined from the 
simulation fits to the experimental results. 
 The stability of the Au nanosnakes (the shelf-life) was tested by comparing the UV-Vis spectra 
immediately after the 640 nm LSPR synthesis to the UV-Vis spectra at 1, 2, and 4 months after synthesis, 
under room temperature storage conditions. As Figure 3.6 shows, no substantial change in the UV-Vis 
spectra occurs, indicating that the sample exhibits long-term stability. 
 
Figure 3.6 UV-Vis spectra of 640 nm Au nanosnakes immediately after preparation, and 1, 2, and 4 months 
after preparation. The black line cannot be seen, as it lies behind the red line. The UV-Vis spectra do not 
significantly change, indicating that the nanosnake sample integrity is maintained.   
 To better characterize the nanosnake samples, solutions with a 590, 610, 620, 630 and 640 nm 
LSPR were deposited on TEM grids for size analysis. Due to the low sample grid density, a combined image 
of TEM crops (single nanosnakes were aggregated into a single image) is given for every sample in Figure 
3.5. As the LSPR of the nanosnakes shifts towards the red end of the spectrum, the correlated chain 





3.4.2 Monte-Carlo Computer Simulations of Nanosnake Formation 
 To model the growth of the nanosnakes, Monte Carlo simulations were run, utilizing a starting 
monomer density of 10-3 (monomers/total lattice sites number) and an applied sticking ratio of 3.3:1 
between the center and the end of the chain, with the starting number of monomers derived from the 
experiment (Figures 3.5 and 3.7). 
 
Figure 3.7 A.) Experimental branching percentages (% unbranched, snake-like linear chains) determined 
via TEM imaging of single nanochains for 590-640 nm (dark blue) LSPR samples (n>200 per sample), the 
best fit of the experimental data (dashed blue line; R2 = 0.87), and Monte Carlo simulation results using a 
sticking ratio of 0.3 for non-end (“center”) chain components (3.3:1 sticking preference of end-over-
middle sticking). B.) Simulated branching results (% of unbranched chains) for various ratios of end-over-
middle sticking (1:1, 2:1, 3.3:1, 5:1, 10:1, 100:1). Out of these samples, an end-over-middle sticking ratio 
of 3.3:1 has the lowest mean squared error (ratiometrically 53x, 11x, 1x, 8x, 59x, 418x respectively). C.) 





LSPR nanosnake sample using a 3.3: 1 sticking ratio (2D projection on square lattice). E.) TEM morphology 
for the 640 LSPR nanosnake sample. F.) Monte Carlo morphology for the simulated 640 LSPR nanosnake 
sample, using a 3.3:1 sticking ratio (2D projection on square lattice). 
Overall, the distributions of the experimental nanosnake lengths (number of Au monomer units 
in snake) highly matches the simulated distributions when a 3.3:1 sticking ratio is utilized (Figure 3.5). 
Furthermore, the morphologies of the nanosnakes look highly similar to the Monte Carlo morphologies. 
As an example, the TEM morphologies of the nanosnakes (590 and 640 LSPR) are shown in Figures 7c and 
7e, with the comparable Monte Carlo simulations in Figures 7d and 7f. Overall, the Monte Carlo 
simulations provide an important insight into the chemical nature of the synthetic method used, where 
attachment to chain-“end units” is favored over attachment to chain “center units”, the ones with more 
than one nearest neighbor; the latter units seem to be better shielded towards chemical attachment (3-4 
times more than the end units), thus accounting for the formation of gold nanosnakes rather than 
producing Au NP globules. The biased sticking probability (3.3:1 ratio) for chain-end units means that the 
aggregation process cannot simply occur from a model of diffusion limited cluster aggregation (DLCA), 
where a non-biased sticking probability (1:1 ratio) would be expected. Instead, this aggregation process 
is likely due to a combination of diffusion and dipole-dipole forces, where dipole moments form at the 
ends of the nanochain and drive preferential sticking, similar to that in the case of previously reported 
nano-metals.36,75,76  
3.4.3 Simulation of the Optical Extinction Spectra of Gold Nanosnakes 
In the field of nanochain plasmonics, a large challenge has been to relate UV-Vis spectra 
quantitively to TEM distributions.77 Indeed, quantitatively establishing a clear correlation between TEM 
and UV-Vis data faces large challenges: 1.) Chains should have few branches, and disordered aggregation 
should be avoided when depositing samples onto TEM grids.77 2.) A quantitative correlation relating TEM 





(monomer, dimer, trimer, etc.) to be known. Because the nanosnakes synthesized in this work are highly 
linear, the first issue of quantitative correlation can be overcome by depositing samples onto TEM grids 
with low density. To help with the second issue, we have used the discrete dipole scattering (DDSCAT) 
package to compute the optical spectra of all the linear chains within the TEM distribution, as shown in 
Figure 3.8. Performing such DDSCAT computations is typically not feasible for long chain lengths (10+ 
monomers), as prior to this publication DDSCAT had not been parallelized to allow computations to be 
performed on multi-core computational clusters. To overcome this computation bottleneck, we 
developed a Python script to run DDSCAT on a Linux-based SLURM cluster, running such computations on 
up to 400 parallelized cores, where parallelization was split along excitation wavelength (350 – 800 nm). 
Hence, instead of a single core computing all the optical wavelengths so as to determine the optical 
extinction, each core only computed 1-2 wavelengths, thus accelerating computation time by 




























Figure 3.8 Optical extinction spectra computed for linear chains (up to 35 mer) assuming a 1.15 nm gap 







orientations of the incoming light (k vector) are averaged to simulate excitation from unpolarized light, 
with y orientation e-field vectors shown above. B.) Linear extinction spectra along the x orientation. Due 
to electric field symmetry, both electric field orientations lie transverse to the chain, so the LSPR shift is 
not observed. C.) Total spectra for 1.15 nm monomer-to-monomer linear chains from averaged x, y, and 
z orientations (equal weight along each orientation) for each chain length. 
Utilizing a linear combination of chains and their frequencies from the TEM distributions, spectra 
were weighted and a combined spectrum was generated (Figure 3.9). The gap distance (distance between 
monomers) is an important parameter that determines the spectral properties of the nanosnakes. Due to 
the gap distances being less than 2 nm, determining accurate distances experimentally is challenging. 
Hence, for the simulations performed, we tested whether we could predict the gap distance via DDA. To 
do so, the mean squared error value (Equation 3.2 in Methods) was determined for each spacing between 
0.75 – 4.00 nm, so as to determine the best fit. Overall, a 1.15 nm gap distance gave the best average fit, 
among all the samples (Figure 3.9). The spectrum generated from the simulation is compared to each 





Figure 3.9 (A-E.) Computationally generated (red curve) and experimental (black curve) optical extinction 
spectra for samples with LSPR ranging from 590 nm to 640 nm utilizing chain length distributions 
determined by TEM and a gap distance of 1.15 nm. F.) The mean squared error (MSE) as a function of gap 
distance between simulated and experimental spectra. A gap distance of 1.15 nm is found to have the 
smallest mean squared error.  
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Within each spectrum we can see both a transverse SPR mode (near 520 nm) and an LSPR mode 
(590+ nm). Overall, both the DDA transverse SPR and the LSPR mode closely match the experimental 
results. In addition to determining the extinction coefficient for each sample, the absorption and 
scattering contributions to the extinction coefficient were also calculated in DDSCAT, using a 1.15 nm gap 
distance, as shown in Figure 3.10. Of high importance is the following observation: As the length of a linear 
cluster of Au NPs grows longer, the scattering contribution to the extinction coefficient substantially grows 
(from a 0.8% contribution in the monomer to a 16% contribution in the 640 nm LSPR sample). This 
increased scattering cross-section of approximately 40x enhancement in scattering amplitude is a major 
advantage of using gold nanosnakes as probes in scattering-based imaging, like dark-field optical 
microscopy. 
Figure 3.10 Relative components of absorption (blue; left axis) and scattering (purple; right axis) that 
compose the extinction spectra (black; left axis) for each sample, A: 590 nm LSPR, B: 610 nm LSPR, C: 620 
nm LSPR, D: 630 nm LSPR, E: 640 nm LSPR, F: 525 nm (monomer) plasmon resonance maxima, determined 
via DDSCAT simulation using 1.15 nm gap distance. As chain length grows, the scattering contribution to 
the extinction coefficent grows rapidly (a shift from 0.8% contribution (monomer) to 16% contribution 
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occurs). In terms of maximum scattering intensity compared to the maximum monomer scattering 
intensity, scattering amplitiude increases by 6.92x, 20.2x, 24.77x, 29.27x, and 39.45x respectively (590 
nm, 610 nm, 620 nm, 630 nm, 640 nm LSPR). For the monomer sample (F), the black line (extinction) is 
hidden behind the blue line (absorption) due to their close overlap. 
To verify the accuracy of the predicted gold nanosnake gap distance via DDA calculation, we 
measured this distance experimentally using high resolution transmission electron microscopy, as shown 






Figure 3.11 High-resolution TEM images of Au nanosnakes, revealing narrow gap distances (0.80 – 1.25 
nm), with an average gap distance of 1.08 nm ± 0.11 nm. Gap distance average standard deviation 
between measurements (n=3) was 0.062 nm. 
The gap distance obtained from the high resolution TEM data lies between 0.80 to 1.25 nm, with 
an average gap distance at 1.08 nm ± 0.11 nm, in excellent agreement with the DDA predicted value of 
1.15 nm.  
3.4.4 Dark-field Light Scattering Microscopy and MTT Cytotoxicity Assay 
           With the optical properties of the gold nanosnakes characterized, RGD peptide-conjugated gold 
nanosnakes, with an LSPR at 640 nm, were incubated with HeLa cancer cells and then imaged under dark-
field optical microscopy (Figure 3.12B). The gold nanosnakes with LSPR at 640 nm were selected for being 
used in the dark-field optical imaging because they have the reddest excitation wavelength (deeper 
penetration depths) and highest maximum scattering cross-section among all samples. RGD peptide-
conjugated Au NP monomers (surface plasmon resonance at about 525 nm) were also incubated with 
HeLa cancer cells, as a control for comparing image properties (Figure 3.12A). As shown in Figure 3.12, 
HeLa cancer cells stained with Au NP monomers and gold nanosnakes appear green and orange, 
respectively, under dark-field optical microscopy. This is because the surface plasmon resonance of the 
gold nanostructures determines the image color when they are used as contrast agents in dark-field light 

























Figure 3.12 Dark-field light scattering images of human HeLa cancer cells stained with (A) 20 nm RGD 
peptide-conjugated Au NP monomers and (B) RGD peptide-conjugated Au nanosnakes with LSRP at 640 
nm. The scale bar is 100 µm. (C). Mean intensity per cell pixel (n = 12 cells) for HeLa cells incubated with 
20 nm RGD-conjugated Au monomers and RGD-conjugated 640 nm LSPR nanosnakes (equal incubation 
masses). 
           Overall, for individual cells within each image, the Au monomers incubated cells have a mean 
intensity per pixel of 48.0 ± 7.78 and the Au nanosnake incubated cells have a mean intensity per pixel of 
118 ± 14.5 (Figure 3.12C), revealing that the Au nanosnakes have a 2.46x ± 0.50x greater mean scattering 
intensity per Au nanosphere, compared to the Au monomer nanospheres. The scattering increase from 








field imaging, as equal masses of gold (equivalent masses of gold nanospheres) were added for both the 
Au nanosnake and the Au monomer samples during cell incubation. This enhancement by about 2.5 also 
closely resembles the predicted DDA per nanosphere enhancement value of 3.35 ± 0.55 (Figure 3.13), and 
may be a bit smaller due to a somewhat less efficient uptake of the larger Au NPs by the HeLa cells. Note 
that Albanese et. al. show that Au NPs on the scale of 20 nm are 20-30% better uptaken than larger Au 
aggregates (on the 100 nm scale).78 
 
Figure 3.13 Computed (DDA) scattering enhancement for 590 nm, 610 nm, 620 nm, 630 nm, and 640 nm 
LSPR nanosnakes under excitation from a tungsten halogen (500 – 700 nm excitation) lamp per 
nanosphere as compared to a 20 nm Au monomer (525 nm LSPR). 
           Applying gold nanosnakes as imaging contrast agents presents multiple advantages. Foremost, 
because the LSPR of the gold nanosnakes is tunable, optical imaging at a selected wavelength, avoiding 
background from cell scattering or other scattering/fluorescent dyes, is possible. Second, images with high 
brightness could be acquired using gold nanosnakes, because of the highly enhanced scattering cross 
section relative to that of the NP monomer. Third, it is advantageous to tune the gold nanosnake optical 





performing in vivo imaging, because near-infrared light travels deeper into tissue, by a factor of 10-100x, 
compared to bluer light, with much lower background fluorescence.79 Fourth, the gold nanosnakes 
synthesized here can be easily conjugated with active targeting moieties, like the RGD peptide shown in 
Figure 3.12, for in vitro and, most importantly, for in vivo targeting. Fifth, the gold nanosnakes have 
intense electric field hotspots between monomers (Figure 3.14) which can serve to enhance near-field 
coupling with fluorescent dyes, currently of immense interest in super resolution, single molecule, and 






Figure 3.14 Electric field distribution of gold nanochain tetramer (4-mer) with 1 nm gap, determined via 
DDSCAT simulation at 636 nm excitation (maximum of tetramer optical extinction from DDA simulation), 
where light travels along the y-axis. The E-field intensity axis is scaled to relative units between 0-300 





gaps, intense electric field hotspots exist. For longer chains, electric field intensity will increase in the gap 
regions. 
            
           Furthermore, biocompatibility was tested for the nanosnake sample on 3 different cancer cell types 
(breast cancer, cervical cancer, brain cancer), up to a mass concentration as high as 0.25 mg/mL, via MTT 
assay. Overall, no statistically significant cell toxicity from the gold nanosnakes was observed (Figure 3.15).   
 
Figure 3.15 MTT assay under gold nanosnake (LSPR at 640 nm) incubation for HeLa (cervical cancer), MDA-





0.25 mg/mL NP mass concentration), revealing that the gold nanosnakes are biocompatible, i.e., show no 
statistically significant cell toxicity effects.                    
           The MTT result reveals that the nanosnake system is well-suited for a variety of bio-imaging 
applications, as across a variety of cell lines there are no significant toxicity effects. In addition, these 
cancer cell targeted gold nanosnakes could potentially serve as carriers of photosensitizers for 
photodynamic therapy and as agents for plasmonic photothermal therapy.11,12,85  
3.5 Conclusion 
           We describe a facile and novel method for a well-controlled and selective synthesis, accompanied 
by careful characterization, of a highly-linear, spectrally tunable, and biocompatible gold nanosnakes 
system, made of nanospheres separated by gap distances less than 2 nm. Utilizing ensemble statistics of 
the nanosnake lengths, determined by a TEM image analysis, DDA calculations reproduced well the 
experimental optical absorption spectra for all the fabricated nanosnake samples. Monte-Carlo 
simulations provide an interesting insight into the selectivity of the specialized chemical synthesis, 
revealing that the chain-end units of these linear clusters of Au NPs are about 3-4 times more reactive 
than their center units; thus gold nanosnakes (highly linear gold nanochains), rather than globular 
assemblies, are formed. It is this linear assembly that enables the spectral tunability property of the gold 
nanosnakes, and this tunability is of high potential for various biomedical applications. Furthermore, these 
nanosnakes show no cytotoxicity, and they can also be easily conjugated with targeting moieties, such as 
the RGD peptide, for targeted therapy applications. Future research on these nanosnake systems may 
proceed along three directions: 1.) Batch synthesizing and characterizing longer nanosnakes with LSPR up 
to 750 nm (small scale synthesis has been successful but the method is currently being optimized); 2.) 
Exploring how the molar ratio between the CALNN peptides and the cysteamine molecules attached onto 
the surfaces of the Au NPs affects the growth of the nanosnakes, the nanochain gap distance (smaller 





formation; 3.) Utilizing these nanosnakes for additional in vitro and in vivo studies. Overall, our results 
demonstrate that the Au NP nanosnake system exhibits many novel properties, including spectral 
tunability and intense scattering cross-sections; we thus expect them to be utilizable for a variety of 
photonic and biomedical applications, such as dark-field and X-ray imaging, as well as targeted theranostic 
modalities. 
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Chapter 4:  Development of Targeted 8-arm PEG Nanosystems for Choroidal Neovascular Macular 
Degeneration Diagnosis and Therapy 
4.1 Abstract 
Wet macular degeneration, also known as choroidal neovascularization (CNV), affects nearly 10% 
of people over 75 in developed countries and is the most aggressive and deleterious form of age-related 
macular degeneration (AMD). Typical treatment includes intravitreal injection of VEGF inhibitors that 
block angiogenesis and slow AMD progression, but these injections must be performed regularly (typically 
monthly) and have associated risks due to their invasiveness. Using a readily conjugatable, 8-arm 
polyethylene glycol (PEG)-fluorescein (FITC) nanosystem, we evaluate its targeting effectiveness when 
conjugated with a high molar concentration of RGD peptide, one of the most commonly used peptides for 
active targeting, for uptake into endothelial cells that make up the invasive AMD vessels. FITC and RGD 
attachment to the PEG nanoparticle, and nanoparticle size distribution were verified using 1D 1H and 2D 
PGSE DOSY NMR spectroscopy. Furthermore, RGD active targeting effectiveness was tested in vitro via 
TIRF microscopy, revealing enhanced localization of PEG-FITC-RGD nanoparticles. Laser-induced choroidal 
neovascularization was performed in vivo in a mouse model to measure RGD uptake effectiveness. It was 
determined that while in vitro targeting was improved by RGD peptide as much as 2-fold, in vivo 
experiments showed more modest NP uptake enhancement of 15-20%. Overall, 8-arm PEG NPs represent 
a new, readily conjugatable nanosystem for potential AMD diagnosis and therapy, wherein new targeting 
moieties or a combined approach of RGD peptide with secondary moieties should be explored in for future 






 Macular degeneration is the leading cause of progressive vision loss among people in developed 
countries  when older than 60, and affects 10% of people over 75.1 While there are several different types 
of age-related macular degeneration (AMD) based on their pathology and molecular drivers, the type of 
AMD known as choroidal neovascularization is a result of angiogenesis that invades the subretinal space, 
which in turn causes photoreceptor loss and vision degeneration.2 This type of AMD is clinically referred 
to as “wet” macular degeneration, due to the increased leakage of fluid or blood into the macula. The 
presence of extracellular deposits known as drusen are common in the early stages of AMD, and the 
disease can progress in later stages to the wet variety.3  While not a lethal diagnosis, macular degeneration 
leads to vision impairment significant enough to prevent an individual from driving, reading, living 
independently, and even recognizing faces.4,5 The exact pathogenesis of wet AMD is not entirely clear, but 
it is hypothesized to be related to a variety of genetic, metabolic, and environmental factors.6 The 
heritability of AMD has been estimated to be between 46-71%, depending on the severity of the disease.7 
There have been 52 genetic variants identified, at 34 different loci that are associated with AMD, many of 
which are related to lipid metabolism, the immune complement system, and the extracellular matrix 
(collagen, glycoproteins, etc.).8 Associations have also been found between AMD progression and genes 
that are typically associated with chronic inflammation, specifically HRF and RPD; these are used as 
biomarkers for inflammation, and likely contribute to the formation of the drusen that induce disease 
progression.9 Other, more broad genetic risk factors include race and eye color, with Caucasians and 
individuals with light colored eyes showing significantly higher rates of wet AMD.10 Obesity has been 
associated with a two-fold increase in risk for AMD, but it is not considered a causative factor in the 
development of the disease.11 Hypertension, both treated and untreated, can lead to a three-fold increase 





The treatment of macular degeneration has two choices: 1.) Anti-vascular endothelial growth 
factor (VEGF) inhibitor-based therapy, which involves a direct intravitreal injection of VEGF drugs into the 
diseased eye; 2.) Small molecule photodynamic therapy (PDT), where photosensitizing dyes that produce 
reactive oxygen species (ROS) are injected and taken up by the neovascular cells; following uptake, 
excitation of the dye by a low power red laser produces the toxic ROS species, killing the cells. The anti-
vascular endothelial growth factor (VEGF) treatments are most common, as they inhibit an important 
factor in the induction of angiogenesis that leads to vision loss, and are highly effective.6 However, anti-
VEGF treatments must be performed frequently (at least monthly) to show effectiveness. Furthermore, 
while the anti-VEGF treatments do show promising therapeutic outcomes, they still carry significant risks. 
Endophthalamitis, typically caused by bacterial infection post-intravitreal injection, has been reported to 
occur in 0.019-1.6% of patients, and is likely a cause of improper sterilization or poor aseptic technique.13 
The anti-VEGF antibody itself can also induce intraocular inflammation that can damage the eye, with 
significant cases at 2.9-14%.13 Lastly, and of immense importance, anti-VEGF therapy prevents the 
worsening of AMD progression, as it prevents growth factors from binding to the VEGF receptor; however, 
it cannot cure AMD. This means that patients must receive anti-VEGF therapy indefinitely, and the 
physician must work to find a balance between the frequency of administering anti-VEGF therapy and 
disease progression so as to prevent worsening of the symptoms. For the reasons listed above, physicians 
and researchers have been pushing for better AMD therapies, especially in the last 20 years. In 2000, 
Verteporfin (pharmaceutical name Visudyne), a small molecule photosensitizer, was approved by the FDA 
for photodynamic therapy of AMD. Photodynamic therapy is the process of exciting a small molecule 
(called a photosensitizer), leading to the production of reactive oxygen species (ROS), which are cytotoxic 
and thus causing cell death. Verteporfin-based photodynamic therapy first targets and then kills the 
endothelial neovasculature that forms in macular degenerative disorders. However, while PDT provides 





the eye, nor is it designed to target cell surface receptors. Current forms of photodynamic therapy are 
achieved using a red laser (693 nm) which excites the photosensitizer. Contrasted with the anti-VEGF 
therapies, which target neovasculature growth factors to prevent endothelial formation, the AMD 
photodynamic therapies destroy the neovasculature itself. Hence, because both therapies have different 
acting mechanisms, it is widely reported that a combined anti-VEGF/PDT approach yields better clinical 
outcomes than either therapy alone.14 Overall, however, current AMD photodynamic therapies have 
several limitations: 1.) Drug localization is not by active targeting, as it accumulates in the retinal 
neovasculature passively; 2.) The Verteporfin-based therapies destroy the neo-endothelilal vasculature, 
but do not ‘cure’ AMD , thus the treatment requires progressive visits to the physician, on average 4 times 
per year; 3.) The presence of submacular hemorrhage and of widely distributed lesions do render the PDT 
less effective.15 An ideal treatment system would localize the photosensitizers in all areas that require 
treatment, while leaving the rest of the eye unaffected. 
Nanoparticles (NPs) have an advantage over currently available ‘small molecule’ therapeutics, in 
that a single NP can carry multiple functional moieties with active, not passive, targeting. Here, we report 
on a FITC-conjugated, fluorescent 8-arm-peg nanoparticle modality that is designed to target the 
endothelial cells of the invasive AMD blood vessels without being injected into the eye. The 8-arm PEG is 
a polyethylene glycol NP that has eight stretched arms, all attached to a hexaglycerol core. These 8-arm 
PEG-based nanoparticles have a small size (5-10 nm), have high biocompatibility, and have multiple 
reactive points for addition of imaging and therapeutic moieties.16,17 Specifically, an amine group at the 
end of each arm allows for functionalization to other molecules. To create a fluorescent nanosystem so 
as to perform fluorescence imaging, fluorescein isothiocyanate isomer I (FITC) is conjugated onto the 8-
arm PEG NP. The thiocyanate group of the FITC molecule is responsible for covalently binding the amine 





To achieve the 8-arm-peg targeting selectivity, an RGD peptide was loaded onto the PEG particle 
at high molar concentrations. The RGD peptide has 15 amino acids (RGDRGDRGDRGDPGC), including a 
cysteine on the carboxy-terminal end that is used in the particle conjugation process. RGD has been shown 
to bind to integrins, a diverse class of proteins that make up part of the extracellular matrix.19,20 
Specifically, the integrin 𝛼v𝛽3 has been implicated in the angiogenic process, with a significant increase 
in expression on highly proliferative cells such as the ones driving the choroidal neovascularization in 
ocular diseases.21 Additionally, the RGD motif has been shown to bind to this specific integrin with high 
affinity.22 This combination of binding specificity and cellular expression makes the RGD motif a natural 
choice for targeting choroidal neovascularization. While previous groups have used RGD “small molecule” 
targeting paradigms to achieve AMD localization,23,24 actively targeted RGD nanoparticle-based platforms 
for treating AMD studied primarily in tandem with other peptides,25 and no studies on any kind of 8-arm-
peg NP have been performed for AMD diagnosis or therapy.  
Figure 4.1 outlines the biomedical framework for the 8-arm-peg system: In CNV-based 
angiogenesis, nanoparticle injection results in localized peg particles in the retinal endothelial cells, which 
can be detected via fluorescence imaging. Such a system can be used to aid in the localization of important 
therapeutic modalities, such as pharmaceuticals and PDT dyes. It should be noted that 40 kDa 8-arm-peg-
based nanosystems, as reported from our group, showed good specificity of localization (using targeting 
peptides like CTP, cardiac targeting peptide) as well as high contrast for bioimaging.16,17 Due to the 
enhanced permeability and retention (EPR) effect, 40 kDa particles tend to accumulate and remain in the 
body for longer periods of time than smaller NPs.26 For cardiac-based therapies, using larger PEG NPs is 
most desirable because myocyte targeting specificity is better thus achieved.16 However, for retinal 
therapy, it is desirable for the NPs to have a short half-life, ideally within 24 hours after injection. 





in bigger NPs, leading to reduced targeting specificity.27 For these reasons, we have utilized a 10 kDa PEG, 
as it is the smallest size 8-arm-peg commercially available.  
Figure 4.1 An overview of the goal of a targeted particle. a. A photocoagulator is used to irradiate the 
retina. b. CNV disrupts the membrane as a result of angiogenesis in the region, thus negatively affecting 
photoreceptors. c. Tail vein nanoparticle injection allows for less pain and smaller chance of infection 
compared to an intravitreal injection. d. The particles localize specifically to the endothelial cells in the 
new blood vessels. e-f. Fluorescent molecule imaging shows the eye and the areas of high signal, indicating 
particle targeting. 
a. Laser induction of CNV b. Angiogenesis disrupting 
photoreceptors 




f. Image analysis 
e. Fluorescent 





Overall, we have succeeded in developing a novel 8-arm PEG fluorescent nanoparticle system that 
showed a nearly 100% improvement the RGD-assisted targeting to mouse aortic endothelial cells 
compared to non-RGD conjugated controls. In vivo experiments showed a more modest improvement, of 
15-20%. Overall, these experiments present a promising new nanosystem for nanoparticle-assisted AMD 
theranostics (therapy and diagnostics) for individuals with wet AMD pathologies, with the potential for 
additional enhancement given the development of new AMD targeting molecules. 
4.3 Experimental Procedures 
4.3.1 Synthesis of the 8-arm PEG particle Derivatives 
The 8-arm PEG FITC RGD particle system consists of four components: the core 8-arm PEG amine 
particle, FITC fluorescent dye, a MAL-PEG-SCM linker, and the RGD targeting molecule. Synthesis proceeds 
the same for both the 10 kDa and 40 kDa particle, as published in previous literature.16,17  A summary of 





Figure 4.2 An overview of the nanoparticle synthesis. a. The conjugation of FITC to the 8-arm PEG Amine 
core. b. The addition of the MAL-PEG-SCM linker. c. The addition of RGD and the capping of any exposed 
maleimide groups. This step separates RGD from nRGD control particles. 
The core 10 kDa 8-arm PEG amine particle (Creative PEGworks) was prepared at a concentration 
of 50 mg/mL in PBS (pH = 7.4), to which a 1.5 molar ratio of fluorescein isothiocyanate isomer I (Sigma 
Aldrich) in DMSO was added and incubated overnight. The addition of FITC to the 10 kDa core particle is 
the most straightforward and insensitive to solvent conditions, and therefore can be accomplished using 
standard phosphate buffered saline (PBS) at a pH of 7.4. As indicated by Figure 4.3a, the amine on the 
core PEG particle acts as a nucleophile, attacking the central carbon in the isothiocyanate group. The 
resulting electron shift and proton loss leaves a stable isothiourea bond.18 The conjugated particle was 
then washed three times each in PBS and ultrapure water in a 50 mL, 3 kDa centrifuge filter (Sigma 








Thiolated compounds (RGD peptide) cannot be conjugated to the amine on the terminus of the 
PEG arms due to incompatibility between the peptide’s sulfur terminus and 8-arm PEG’s amine terminus, 
and a linker must therefore be added to bridge these functional groups. Maleimide-PEG-Succinimidyl NHS 
ester (MAL-PEG-SCM) is a heterobifunctional PEG product that allows for the unidirectional addition of 
the linker, ensuring that the proper functional groups are available for RGD addition.17 The succinimidyl 
ester end covalently binds the amine of the PEG particle, while the maleimide on the opposite side is able 
to bind the thiol of the terminal cysteine in the RGD peptide. To conjugate the MAL-PEG-SCM linker, the 
8-arm PEG FITC particle was prepared at a concentration of 20mg/mL in 10x PBS at a pH of 7.2. A 12:1 
molar ratio of MAL-PEG-SCM (Creative PEGworks) was prepared separately at 100 mg/mL in 10x PBS pH 
7.2, and the two were combined for 1 hour. The amine again acts as a nucleophile, this time on the 
carbonyl of the succinimidyl NHS ester. The electron movement from the charged oxygen then kicks off 
the NHS leaving group, completing the substitution reaction, as shown in Figure 4.3b.18 The 
maleimide/succinimidyl NHS ester linker is sensitive to pH and time. PBS must be adjusted to pH=7.2 and 
increased to 10x concentration to optimize the bond formation between the core particle and the linker. 
This decrease in pH also favors the formation of the bond between maleimide and its eventual target 
(RDB) and reduces the rate of ring opening, which would render the linker nonfunctional.18 The newly 
linker-conjugated particles were then washed in fresh centrifuge filters three times each in 10x PBS pH 
7.2 and pure water. At this point, 8-arm PEG FITC MAL particles that were used as controls, lacking the 
RGD targeting group, were capped with 15 molar equivalents of cysteine in pure water for 1 hour. This 
binds the reactive maleimide group and prevents the particles from cross linking. These were referred to 
as nRGD particles. For the particles that were to be conjugated to RGD, 15 molar equivalents of the 
peptide (MW: 1588 g/mol) were added to the 8-arm PEG FITC MAL in pure water and incubated overnight. 
It should be noted that RGD is susceptible to degradation. The aspartate residue (the D in RGD) is capable 





backbone carbonyl or amide nitrogen. This creates a 5 or 6 membered ring and a charged oxygen that 
kicks off the rest of the peptide.28 For this reason, the washes after RGD conjugation must be done 
immediately after synthesis, and the particle must then be lyophilized. These were then capped with the 
same 15x molar equivalent ratio of cysteine as nRGD and incubated for an hour. Maleimide reacts with 
thiols in both RGD and cysteine, where the thiolate anion acts as a nucleophile for one of the carbons 
involved in the double bond. Electron shift results in an increase in electron density at the other carbon, 
which then gains a proton from the bulk solvent, as indicated by Figure 4.3c.18  All particles were washed 















Figure 4.3 An overview of the mechanistic steps of nanoparticle synthesis. The designation R’ indicates 
the side of the growing nanoparticle, while R is the molecule being added. a. The conjugation of FITC to 
the 8-arm-PEG amine core through the formation of an isothiourea bond. b. The addition of the MAL-PEG-
SCM linker through the substitution of the succinimidyl NHS ester. c. The addition of RGD via addition to 
the maleimide group on the linker. 
 
a. 8-arm PEG FITC 
b. 8-arm PEG FITC MAL 





4.3.2 Verification of Nanoparticle Synthesis and Measurement of Nanoparticle Size 
To verify that the 8-arm-peg functional conjugations (FITC, RGD) were successful, 1H NMR 
spectroscopy was utilized to identify presence of relevant attached functional groups. Spectra were taken 
of each individual component of the system separately to determine baselines for the respective 
components of the particle synthesis. Then spectra were taken at each step when possible so that the 
structure of the synthesized intermediate could be determined, i.e. if the two parts had joined properly.  
The size of the core 8-arm PEG particle was determined using NMR diffusion ordered 
spectroscopy, or DOSY. Approximately 5 mg of PEG NP was dissolved in 600 μL D2O, and a pulsed gradient 
spin echo (PGSE) experiment was performed. The fundamental basis of the PGSE experiment is in a 
sequence that starts with a 90° magnetic pulse followed by a 180° pulse. Between these pulses a magnetic 
gradient is applied that dephases the precession induced by the first pulse. The 180° pulse flips the 
direction of precession, and another, identical gradient is applied. In a hypothetical scenario, if there is no 
diffusion, this second pulse would reverse the initial dephasing done by the first pulse and all spins would 
be realigned. However, due to particle diffusion, the signal is not fully refocused, and signal attenuation 
occurs. The rate of this attenuation can be used to calculate the diffusion coefficient.29–31 Pairing this 
experiment with a processing technique known as diffusion ordered spectroscopy (DOSY) allows for the 
calculation of the diffusion coefficient from the spectra created by the PGSE procedure.32 This technique 
creates a 2-dimensional plot with chemical shift on the x-axis and the diffusion coefficient on the y-axis. 
Because the nanoparticle has a distribution of size, a weighted average was taken by the software to 
determine the average diffusion coefficient. This calculated value (Dtrans) could then be substituted into 
the Stokes-Einstein equation (Equation 4.1), along with the viscosity (η) of D2O (1.2467) and temperature 
(35 C), and the radius of the particle was determined.17  





4.3.3 Maintenance of Cell Culture 
Before beginning in vivo experiments, cell culture was first utilized to verify the effectiveness of 
the targeting moieties. To approximate the neovascular cells present in wet macular degeneration, mouse 
primary aortic endothelial cells (MAEC) were used (Cell Biologics). These cells have been used to emulate 
vascular endothelial cells in obesity, diabetes, and wet macular degeneration.23,33,34 As MAECs are somatic 
cells, they are not immortal and cell passage must be tracked. Cells were maintained in DMEM with 5% 
FBS, 1% penicillin/streptomycin, and 1% antibiotic-antimycotic (Gibco). Cultures were maintained and 
split every 48-72 hours, and passage number was recorded. Splitting began with aspirating the spent 
media off the cells and washing twice with sterile DPBS (Gibco). Clean cells were then incubated with 
trypsin 0.25% (Gibco) for 5-8 minutes, or until cells were released from the surface of the culture dish. 
Using pre-warmed media, cells and trypsin were transferred to 15 mL centrifuge tubes and spun at 500 g 
for 5 minutes. The media-trypsin mixture was aspirated off the cell pellet, which was then combined with 
fresh media and aliquoted into clean T75 culture flasks. Each flask was typically plated with 5x105 to 1x106 
cells. Cells that were to be frozen were combined with freezing media, consisting of 50% FBS, 40% normal 
cell media, and 10% DMSO, after the centrifugation step. They were kept at -20° C for 15 minutes before 
being transferred to liquid nitrogen. 
4.3.4 Cell Loading Experiments: TIRF Imaging and Analysis 
Loading experiments were conducted on small, glass-bottom cell culture plates. The plates were 
incubated with 1x105 cells each and allowed to grow for 24 hours. Cells were treated with varying 
concentrations of control (nRGD) and RGD particles and incubated for 24 hours. The following day, after 
washing 5 times with DPBS, fresh media was added to keep cells viable. Total Internal Reflection 
Fluorescence (TIRF) microscopy was used to image and quantify the loading of the particles in the MAEC 





light is reflected back into the microscope. This technique allows for resolution of a very thin horizontal 
plane in the cell (also known as the optical section), and the near total elimination of background 
fluorescence means images can easily be quantified.35 ImageJ was used to determine the intensity of light 
fluorescing off the cells, which correlates to the success of the targeting peptide RGD. Using the software, 
representative images had background light eliminated, and the pixel intensity along a line was measured. 
The maximum intensity was averaged with that of 5 other images and this average was used for 
comparison with the other concentrations. 
4.3.5 In vivo experiments using a C57BL/6 mouse model 
C57BL/6 mice were used as the in vivo model. To induce neovascularization in the eye in a 
carefully controlled way, a photocoagulator is used to disrupt Bruch’s membrane. The protocol used is 
based on previously published studies.36 This method is the most reliable way to induce 
neovascularization, whereas injections of viral vectors overexpressing VEGF are much less effective.36 
Imaging of the eye was performed through a combination of two techniques. First, images of the eye itself 
were captured using a method known as optical coherence tomography or OCT. This process is non-
invasive and allows for resolution of around 5-10 μm. Where standard spectroscopy suffers from high 
background due to random scattering of light, OCT uses this background light to measure interference 
with a reference beam. This allows for a computational process that eliminates background from the final 
image, giving high resolution.37 The second method was fluorescent molecule spectroscopy, and 
specifically was meant for measuring the fluorescence of the nanoparticle in the eye. Used in tandem, it 
is possible to get a clear picture of the area of neovascularization and particle localization in the same 
image.  
Adult, 6-8-week-old C57BL/6 mice weighing 19-21 g were utilized for in vivo studies. For CNV 





via intraperitoneal (IP) injection. Before the experiment, the pupils were dilated with a topical application 
of phenylephrine hydrochloride 2.5% and tropicamide 1%. Topical tetracaine drops were applied prior to 
the experiment for additional anesthesia. A home-made, small table allowed for the movement of the 
mouse to align with the laser properly and was also equipped to maintain mouse body temperature 
through resistor-based heating. Balanced Salt Solution (BSS, Altaire Pharmaceuticals, Inc., Aquebogue, NY) 
was used to wash the cornea and keep it moist. Baseline OCT and fluorescent molecule images were taken 
using free fluorescein sodium (10%, 0.1 ml/kg, Akorn Inc, Lake Forest, IL) injected intraperitoneally. After 
imaging, oculentum was applied to the cornea to protect it and minimize inflammation. 
To reduce laser scattering, the cornea was covered by a glass slide coupling with gel. CNV was 
induced through irradiation using an argon green laser to burn Bruch’s membrane. The laser was focused 
on the eye through a slit lamp with 75 μm spot size, 100 mW power, and 100 ms duration. Because of the 
inherent variability of the system, four burns were induced around the optic nerve in each mouse to 
ensure at least one success. Oculentum was applied after treatment. Mice were then housed for 7 days 
to allow the CNV to manifest. Imaging using free dye was then done again to determine the success of the 
laser treatment prior to nanoparticle injection. An additional day of waiting allowed for free dye to 
naturally leave the system. After evaluation of the success of the CNV, nanoparticles were injected 
through the orbital venous varix in the tail (20 mg/mL, 10 mL/kg). Images were taken again immediately 
following nanoparticle injection and after 8 and 24 hours. 
All mice were treated in accordance with the ARVO (The Association for Research in Vision and 
Ophthalmology) Statement for the Use of Animals in Ophthalmic and Vision Research. All experimental 
procedures were approved by the Institutional Animal Care & Use Committee (IACUC) at The University 





4.4 Results and Discussion 
4.4.1 8-arm PEG Synthesis and Characterization via NMR Spectroscopy 
  8-arm-peg NPs were synthesized with attached fluorescent fluorescein (FITC; 1.5x molar ratio) 
and attached RGD peptide (6x molar ratio) or using a non-RGD control (‘nRGD’; 6x molar ratio). To 
characterize each sample, 1H NMR spectroscopy was utilized, with 2D DOSY NMR spectroscopy used to 
determine the NP size. For the 1H NMR spectroscopy, the elongated polymeric nature of the 8-arm PEG 
particle means that the NMR spectra have very intense peaks at the chemical shifts associated with 
ethylene glycol. Of the peaks seen on Figure 4.4a, that which is centered around 3.73 ppm is the peak 
associated with the ethylene glycol functional group. The peak at 4.8 ppm is due to residual water from 
the solvent, while that at 3.02 ppm is the primary amine at the end of the polymer chain. The amine peak 
is an important indicator for the success of the linker conjugation, as it changes from a primary to a 
secondary amine as the new bond is formed. Additionally, due to the high intensity of the PEG peak, any 
peaks from other substituent groups, such as FITC, RGD, or the linker, must be verified at chemical shifts 
outside of 3-4 ppm. The characteristic peaks used to verify FITC conjugation were the cluster at roughly 
6.5-6.7 ppm as shown on Figure 4.4b. These peaks correspond to the hydrogen atoms on the aromatic 
rings, and are a unique feature not shared by any other particle components. From Figure 4.4e, these 
peaks can be clearly seen from 6-7 ppm. Being an oligopeptide consisting of five distinct amino acids, RGD 
has a complex NMR spectrum shown in Figure 4.4d, with several peaks in the same area as PEG. For this 
reason, the peaks used to verify RGD addition were those from 7.5-8.5 ppm. The presence of peaks in this 
range can be seen in Figure 4.4e, indicating that all necessary components were successfully conjugated 
to the 8-arm PEG core particle. The MAL-PEG-SCM linker, being primarily made up of PEG like the core 





bind the amine of the core particle, its presence in the completed particle shows that the MAL-PEG-SCM 
linker was conjugated properly.  
Figure 4.4 a-d. 1H NMR spectra for each component of the nanoparticle synthesis. a. 10 kDa 8-arm-peg 
base NP b. fluorescein isothiocyanate (FITC) c. 2kDa maleimide-PEG-succinimidyl N-hydrosuccinimide 








The 2D DOSY spectra are shown for the core 10 kDa and 40 kDa particles in Figure 4.5. Because 
the PEG NP is a polymer with a distribution of lengths, there are modest variations (±10%) in NP size, and 
therefore 4 major 2D NMR peaks are observed, instead of 1 peak for a NP of single size.  
Figure 4.5 2D DOSY NMR spectra for the core 8-arm PEG amine particle. The axis range is narrow (±10%), 
wherein peak differences represent variations in total particle mass. a. The 10 kDa 8-arm-peg NP utilized 







Figure 4.5a and 4.5b show the four most intense peaks measured in the 10 kDa and 40 kDa 
particles, respectively. Averaging these 4 peaks, the 10 kDa particle had an average diffusion coefficient 
of 7.619x10-11 m2/sec, and substitution into the Stokes-Einstein equation (Equation 4.1 in Methods) yields 
a diameter of 5.178 nm. The 40 kDa particle had an average diffusion coefficient of 3.891x10-11 m2/sec, 
which corresponds to a computed diameter of 10.14 nm, in agreement with published literature of the 40 
kDa particle.17 
4.4.2 In-vitro TIRF Imaging of RGD-Conjugated 8-arm-peg NPs  
In vitro total internal reflectance fluorescence (TIRF) cell imaging was performed using 8-arm-peg 
nanoparticles when conjugated to RGD peptide and without RGD peptide (‘nRGD’) to study the RGD-
assisted NP uptake, as shown in Figure 4.6. Quantifying the NP uptake, the highest concentration of 8-
arm-peg-RGD incubated sample, at 3 mg/mL, produced the largest contrast between RGD and nRGD-
loaded PEG NPs (Figure 4.6a). Based on the pixel intensity of the analyzed images produced by the TIRF 
system, there was a 104% increase in particle loading attributable to the RGD peptide. This separation 
gradually decreased with incubated PEG NP concentration, with the 1 mg/mL condition increasing 
intensity 64%, the 0.5 mg/mL increasing 41%, and the 0.3 mg/mL increasing 31%. Qualitatively, it can be 
seen in Figure 4.6b that each RGD image appears noticeably brighter than the corresponding nRGD image, 
wherein the brightness also appears to attenuate at lower concentrations. Interestingly, while the size of 
the 10 kDa PEG NPs (5 nm) is small enough to enter the nucleus, the particles form a crescent or hollow 






Figure 4.6 Summary of results from the cell loading experiments and TIRF microscopy imaging. a. 
Quantitative analysis of the four concentrations with standard deviation used for error bars. Intensity 
refers to the calculated value of pixel brightness from the image analysis. b. Representative images from 
each concentration and condition. Note that background appears to increase slightly as concentration 







Overall, because both RGD and nRGD loaded cells were incubated for the same amount of time 
and at the same concentration, factors other than EPR effects or concentration gradients across the 
membrane must account for the improvement due to RGD. Hence, the in vitro 8-arm-peg imaging results 
give strong support to the notion that RGD improves the NP-assisted cell binding and uptake at relevant 
biological concentrations, most likely due the binding affinity of the RGD peptide to the integrin protein 
𝛼v𝛽3, which leads to a greater rate of cellular uptake.19–21  
4.4.3 In vivo Imaging of RGD-Conjugated 8-arm-peg NPs 
The success of the cell loading experiments in vitro prompted translational in vivo testing, 
preliminarily with two mice that had induced retinal neovascularization, one mouse receiving RGD and 
the second mouse receiving nRGD PEG NP injection. The results, seen in Figure 4.7, reveal increased RGD 
signal intensity relative to the nRGD control. Small spots around the periphery of the spider-like 






Figure 4.7 Images of the retina in RGD and nRGD treated mice. The large blood vessels indicated by high 
fluorescence are normal in the eye, whereas the fluorescence near the edges represents CNV lesions being 
illuminated by nanoparticles. 
In both RGD and nRGD conditions, there is visible fluorescence in these spots 10 minutes after 
incubation, indicating some particle uptake. After 24 hours, the neovasculature of the RGD treated mouse 
is substantially brighter than that of the nRGD treated mouse vessels. This indicates that in these mice, 
the RGD peptide was able to enhance particle binding and uptake to the CNV endothelial cells to such a 





To improve statistical significance, the experiment was repeated with more mice, four in each 
condition. Representative images for two mice in each condition are shown in Figure 4.8.  
Figure 4.8 Representative images from the second mouse experiment with a higher number of mice used. 
Baseline refers to the injection of free dye used prior to particle injection, meant to show the success of 
the CNV induction. Clouding of the eye can be seen in the 8- and 24-hour images of some mice. 
Mice treated with nRGD showed little increase in fluorescence over time, similar to the mouse 
experiment in Figure 4.7. Spots along the edge of the eye at the start looked dull and only slightly 
increased in intensity in contrast. In contrast, the mice treated with RGD targeting NPs show modest 






This study evaluated fluorescent 8-arm-peg NPs for RGD-assisted targeting to the age-related 
macular degeneration (AMD) neovasculature. In vitro experiments reveal a strong, measurable difference 
between nRGD (no RGD) and RGD targeting, with RGD providing up to approximately a 100% increase in 
NP uptake. Furthermore, cell uptake of NPs with RGD targeting shows concentration dependence, with 
the highest incubated NP concentration providing the greatest in vitro contrast. In vivo experiments at 
high incubated PEG concentrations (20 mg/mL injections) showed approximately 15-20% in targeting 
signal enhancement due to NP targeting. To improve PEG NP in vivo targeting, several future directions 
are being explored. Previous studies have indicated that RGD works better when used together with other 
targeting agents (‘dual targeting’) to treat AMD.25 Therefore, iobenguane (MIBG) derivatives are being 
synthesized to be used as an alternative, or to be used in tandem, with the commonly utilized RGD 
peptide.39 New studies have indicated that in CNV endothelial cells, the β-adrenergic pathways are 
upregulated, providing a target that is relatively specific for a hypothetical MIBG-bound nanoparticle, as 
this small molecule targets norepinephrine receptors and transporters (NET).40,41 Current work in our 
group has led to the successful synthesis of a form of MIBG that contains the requisite thiol functional 
group necessary to be conjugated directly to the MAL-PEG-SCM linker. Additional studies are planned to 
evaluate PEG NP theranostic effects when conjugated with photosensitizers, namely Verteporfin and Ce6. 
Overall, 8-arm PEG NPs represent a new, readily conjugatable nanosystem for potential AMD diagnosis 
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Chapter 5: Summary and Future Directions 
5.1 Summary 
 This dissertation has evaluated new nanobiophotonic platforms for nanotherapy and 
nanoimaging applications, including polyacrylamide (PAAm)-encapsulated metal clusters, plasmonic 
nanosnakes, and RGD-targeted fluorescent 8-arm-peg NPs. Overall, synthesizing and characterizing new 
nanobiophotonic systems remains one of the most important active fields of research in the 21st century. 
At the present, nanoparticles have reached a threshold where biocompatible NPs with controllable size, 
morphologies, and functionality are becoming not only more widely fabricated and utilized, but also more 
highly specialized. Following this trend, each nanobiophotonic platform evaluated in this dissertation has 
rather specialized utility, with clear advantages as a new nanomaterial for specific applications in cancer 
therapy, plasmonic imaging, and disease targeting. 
 Chapter 2 of this dissertation examined polyacrylamide (PAAm)-encapsulated metal clusters for 
applications in two-photon photodynamic therapy. These PAAm-Au25 NPs show (1) highly enhanced cell 
biocompatibility and (2) greater cell uptake, compared to the non-embedded gold cluster. Furthermore, 
we demonstrate highly efficacious in vitro two-photon PDT for these PAAm-Au25Capt18 NPs, exhibiting a 
tremendous enhancement in 2p-PDT-mediated cell death over one-photon PDT-mediated cell death. 
This enhancement is associated with the high non-linear optical absorbance cross-section of the Au25 
cluster. We show that as a new two-photon photodynamic agent, the Au25Capt18cluster, (a) has a two-
photon cross-section 8x bigger compared to TMPYP, the most highly currently used two-photon 





excitation, with the potential for this efficiency to be improved, and (c) when embedded in hydrogel 
NPs, its optical properties are maintained while achieving better biocompatibility and tumor uptake. 
Chapter 3 of the dissertation examined highly linear plasmonic nanochains of gold nanospheres, 
which we call “nanosnakes”. These nanosnakes are self-assembled from bare Au nanosphere 
monomers, produced by laser ablation (green and chemical-free synthesis), where the monomers are 
surface conjugated with small, biocompatible molecules so as to induce their assembly. These 
nanosnakes have several highly desirable properties for biological imaging: 
1.) Two plasmonic modes are present in each nanosnake sample, one fixed mode at 525 nm 
(monomer mode) and a second tunable mode. The secondary tunable mode varies from 590 nm 
to 640 nm, with tunability within 1-2 nm. Such tunability towards the infrared is a highly 
desirable property in plasmonic imaging due to these photons’ deeper tissue penetration as well 
as due to the much reduced background cell fluorescence. 
2.) The nanosnakes possess scattering cross-sections up to 40x higher than Au nanosphere 
monomers (approximately 3x higher per chain monomer nanosphere), thus making them better 
contrast agents for imaging applications, since gold NPs are utilized for both dark-field and X-ray 
imaging. 
3.)  The nanosnakes can be easily conjugated with active targeting moieties for applications such as 
targeted cancer and heart disease phototherapy and they are also non-toxic to cells, even at 
very high concentrations, where concentrations as high as 0.25 mg/mL NP mass concentration 
(OD:5) were tested, thus adding to their biomedical promise. 
To rigorously characterize these Au nanosnakes and demonstrate the biomedical potential of this 
new nanomaterial, several important experimental and theoretical studies were performed: 
1.) Collecting thousands of TEM images for accurate statistical averaging of the nanosnake samples. 





3.) Plasmonic computations (discrete dipole approximation, DDA) to reveal the nanosnakes’ 
spectral properties (extinction, absorption, scattering, electric field) and to correlate the UV-Vis 
spectra directly with the TEM data. 
4.) Biocompatibility (MTT) tests regarding the cell toxicity of the nanosnakes. 
5.) Dark-field imaging experiments that show the in vitro imaging benefits of the Au nanosnakes, 
compared to Au monomer nanospheres. 
Chapter 4 of the dissertation evaluated fluorescent 8-arm-peg NPs for their RGD-assisted 
targeting to the age-related macular degeneration (AMD) neovasculature. In vitro experiments revealed 
a strong, measurable difference between non-targeted and RGD targeted NPs, with the RGD targeted 
ones showing nearly a 100 % increase in NP uptake. Specifically, the 8-arm-peg-based RGD targeting 
exhibits a concentration dependence, with the highest incubated NP concentration (3 mg/mL) providing 
the greatest in vitro contrast. In vivo experiments at high incubated PEG-RGD concentrations (20 mg/mL 
injections) showed approximately 15-20% enhancement in targeting signal when compared to non-RGD 
controls. Overall, we show that 8-arm PEG NPs are a new, readily conjugatable and targetable nanosystem 
for future optimized AMD diagnosis and therapy, with potential benefits for in vivo theranostic 
enhancement. 
 
5.2 Future Directions for PAAm-Au25Capt18 Embedded Clusters and 2-p Photodynamic Therapy 
5.2.1 Enhancing the Reactive Oxygen Species (ROS) Production Efficiency of Au25(Capt)18 Clusters 
 As discussed in, “Synthesis and Optical Properties of Two-Photon Absorbing Au25(Captopril)18-
Embedded Polyacrylamide Nanoparticles for Cancer Therapy” (Ch. 2), Au25Capt18 clusters have a high two-
photon absorption cross-section (830 GM), but their reactive oxygen species production efficiency is low 
(approximately 1%), most probably due to the relatively short excited-state lifetime of the Au25Capt15 





microseconds, depending on the exact Au25 variant utilized.2,3 Well-known photosensitizers like Rose 
Bengal (RB), Methylene Blue (MB), and the two-photon photosensitizer Meso-tetrakis(N-methyl-4-
pyridyl)porphine tetrakis(p-toluenesulfonate) (TMPYP) have much longer excited state lifetimes (>100 
µs),4,5 and therefore have ROS production efficiencies of 75%, 50%, and 18.2%, respectively.1 
 To improve the excited state lifetime of the Au25(Captopril)18, synthetic approaches should be 
considered so as to modify the cluster. Several groups have shown that the ligands of the Au25 cluster 
influence the lifetime of its excited-state.2,8 Stamplecoskie et. al. has even developed a charge-transfer 
system, utilizing an Au25 cluster variant, with quantum transfer efficiencies exceeding 10%.2 It is 
imaginable that such a charge-transfer system could be used to pass the excited state photon to a long-
lived excited state chromophore. Overall, ligand modification or adding a charge-acceptor moiety are both 
reasonable possibilities to lengthen the excited state lifetime of the cluster. To modify the Au25Capt18 
cluster, we first must consider the chemical structure and morphology of Au25Capt18, as shown in Figure 
5.1. 
 
Figure 5.1 Structure of the Au25Capt18 cluster. The ‘R’ moiety (captopril ligand) has a carboxylic acid group 





 For Au clusters with terminal carboxylic acid groups, like that of the Au25Capt18 cluster, 1-Ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDC) and NHS-derivatives can be used to activate the carboxylic 
acid for reactive chemistry.9 Upon activation, the captopril ligands of the Au25 cluster would have an NHS-
ester terminus for conjugation onto primary amines. Overall, ligand modification strategies following this 
activation paradigm should be considered for improving the Au25 ROS production efficiency.  
 It should be noted that Abbas et. al. propose an alternative way of modifying the optical 
properties and excited state lifetime of the Au25 cluster, namely via chemically doping the cluster with 
other metals.8 While this suggestion is very reasonable for photovoltaic applications, for biological 
applications, and especially two-photon photodynamic therapy, chemical doping should be considered 
carefully. Foremost, while dopants like silver (Ag) and platinum (Pt) have been tested for Au25 clusters, 
only mercury (Mg) and cadmium (Cd)-doped clusters have been discovered to preserve the long excited-
state lifetime of the Au25 cluster, yet both metals are notable for their extreme biotoxicity.8,10 Additionally, 
iridium-doped Au clusters are a promising Au25 variant, yet their excited state lifetimes have not been 
investigated to date.11 Secondly, as Abbas notes, the stability of doped clusters is significantly lower of 
pure clusters.8 For two-photon photodynamic therapy, due to the intense power of the beam, stable 
clusters should be utilized whenever possible. Thirdly, while cadmium doping extends the Au24Cd excited 
state lifetime by 100% (100 ns to 200 ns),10 this change in lifetime is not likely to raise the ROS production 
efficiency from 1% to >10%, but rather by more marginal increases. Still, improving the ROS production 
efficiency of Au25 by >10% could be a major goal for future research, so that gold nanoclusters can 
compete with other classes of photosensitizers. However, research into doped nanoclusters is one of the 






5.2.2 Extended Research into Two-Photon Reactive Oxygen Species (ROS) Sensing 
 In doing research on PAAm-encapsulated Au25Capt18 clusters, it has become obvious that 
analytically evaluating two-photon photodynamic therapy (2p-PDT)-based reactive oxygen production, 
and even two-photon absorption (especially for molecules with small quantum yields like the Au25 cluster), 
should be further developed. For example, anthracene-9,10-dipropionic acid (ADPA) and singlet oxygen 
sensing green (SOSG), both standard probes for measuring reactive oxygen species (ROS) production, do 
exhibit substantial fluorescent changes under TPA excitation (800 nm), even without the presence of a 
photosensitizer. This change in fluorescence in the absence of photosensitizer renders both ADPA and 
SOSG unusable probes for the direct measurement of the production of two-photon ROS species. In 
“Synthesis and Optical Properties of Two-Photon Absorbing Au25(Captopril)18-Embedded Polyacrylamide 
Nanoparticles for Cancer Therapy” (Ch. 2), to solve this problem, we instead measure the one-photon 
reactive oxygen species (ROS) production of Au25Capt18 and PAAm-Au25Capt18 encapsulated clusters  (400 
nm excitation).1 It is well-known that excited state lifetimes, when compared between one-photon 
excitation and the equivalent energy of two-photon excitation, show little change, as the excited state 
transition is equivalent.12 However, directly measuring two-photon reactive oxygen species (ROS) 
production would be more desirable than via an indirect one-photon measurement. Additionally, by 
directly measuring two-photon ROS efficacy, the power dependence of the ROS generation can be 
evaluated, which may also serve as a tool to determine the two-photon absorption cross-section if the 
ROS efficiency were known a priori.  
 For the reasons discussed above, research in the Kopelman laboratory has also extended to 
developing two-photon reactive oxygen species (ROS) sensing dyes. Namely, dichlorofluorescein (DCF) 
derivatives have been synthesized and are being evaluated for their ROS species production under one-
photon and two-photon illumination. Additionally, we are working on encapsulating these DCF derivatives 






5.3 Future Directions for Highly Linear, Tunable, Strongly Scattering Plasmonic Nanosnakes 
5.3.1 Synthesis and Characterization of Higher Linear, Spectrally Scattering Plasmonic Nanosnakes with 
Extended Longitudinal Surface Plasmon Resonances 
 Within “Gold Nanosnakes: Controlled Synthesis of Linear Nanochains with Tunable Plasmon 
Resonance for Nano-Biophotonics” (Ch.3), we successfully synthesized and characterized plasmonic 
nanosnakes with longitudinal surface plasmon resonances (LSPRs) up to 640 nm. While this plasmonic 
shift is large (>100 nm) when compared to the 20 nm Au monomers (520 nm), we are now able to fabricate 
highly tunable nanosnakes with LSPRs up to 750 nm. We note that the further the shift into the IR spectral 
range, the higher the biomedical benefits. We are working on characterizing these ultralong nanosnakes 
in a follow-up publication, with similar TEM analysis used to determine the mass lengths and branching 
ratios of each sample. 
 It should be noted that in such future work, studying longer nanosnakes opens new avenues for 
Monte Carlo simulations. Namely, for long nanoparticle chains, the fractal dimensions of the chains can 
be experimentally determined and compared to the Monte Carlo simulations. The Fractal Dimension is a 
measure of an object’s topological dimension,13 which would lie between 1 (1D) and 2 (2D) for the Au 
nanosnakes deposited on a TEM grid. By changing ligand ratios on the surface of the nanosnake, we 
predict that it may be possible to ‘tune’ the fractal dimension of the Au nanosnakes. 
 Also of importance is the diffusion coefficient used for the Monte Carlo simulations. The diffusion 
coefficient most closely relates to the assembly time (kinetics) of the cluster. In “Gold Nanosnakes: 
Controlled Synthesis of Linear Nanochains with Tunable Plasmon Resonance for Nano-Biophotonics” (Ch. 
3), we assumed that the diffusion coefficient was proportional to 1/m, where m is the mass of the cluster. 
However, when measuring the experimental assembly time for each LSPR sample, we discovered that the 
diffusion coefficient of the nanosnakes is instead proportional to 1/m2. Running Monte Carlo simulations 





(nanochain morphology in our case), but using the correct diffusion coefficient is necessary to correlate 
experimental assembly kinetics to theoretical (Monte Carlo) assembly kinetics.14 Hence, we also plan to 
further explore Monte Carlo simulations with 1/m2 and 1/m3 like diffusion coefficients, and possibly 
fractional diffusion coefficients, to better understand the nanosnake assembly kinetics. 
 Lastly, unlike in “Gold Nanosnakes: Controlled Synthesis of Linear Nanochains with Tunable 
Plasmon Resonance for Nano-Biophotonics” (Ch.3), discrete dipole approximations (DDA) computations 
for longer plasmonic nanosnakes are substantially more difficult. Foremost, with longer nanosnakes, 
longer chains will need to be computed to correlate TEM distributions to extinction spectra. Running 
longer samples (therefore containing higher number of point dipoles) increases computational time by a 
factor of 6-8 as the radius doubles. However, of more concern, the 1 dipole-per-nanometer (dpnm) 
simulations reach an asymptote at 650-660 nm LSPR with increasing numbers of monomers. In most 
plasmonic studies, using 1 dpnm to build plasmonic morphologies is more than sufficient for simulation 
accuracy.15 However, as the chain length grows longer, the electron density between the monomer gaps 
becomes more sensitive to dpnm increases. For example, running a 30-mer with 2 dpnm density yields a 
LSPR maximum of 750-800 nm, whereas the 1 dpnm density has an LSPR near the 650 nm asymptote. 
Hence, to solve this problem, higher dipole-per-nanometer densities need to be run for long nanosnake 
samples. However, 2 dpnm simulations are very costly and time prohibitive – a single 30-mer computation 
could take > 1 week utilizing 30 cores. To solve this problem, adopting an approach similar to Tserkezis et. 
al., in running simulations with higher dipole counts along boundary regions (i.e. gap interface), should be 
considered.16 This may solve the dpnm issue caused by the nanosnake gaps, and allow the simulations to 
be more cost-effective. 
5.4 Future Directions for Fluorescent 8-arm-peg NPs for the Treatment of Macular Degeneration 
5.4.1 Synthesis of Thiolated Iogenguane (MIBG) Derivatives for Targeted Macular Degeneration Imaging 
 In “Development of Targeted 8-arm PEG Nanosystems for Choroidal Neovascular Macular 





imaging of the macular degeneration vasculature. Overall, the in vitro RGD-targeting NP uptake showed 
approximately 100% (3 mg/mL incubation) uptake when compared to non-RGD NP controls, and in vivo 
targeting showed 15-20% increased uptake. Previous studies have indicated that RGD works better when 
combined with other targeting agents (‘dual targeting’) for nanoparticle-assisted AMD localization.17 To 
improve the targeting efficiency, we are synthesizing a secondary moiety that can work in tandem with 
RGD, a thiolated iobenguane (‘MIBG’) derivative. MIBG binds to the norepinephrine transporter (NET) in 
cells that have adrenergic activity.18 While retinal cells typically do not have high levels of adrenergic 
receptors, upregulation of the β-adrenergic pathway has been associated with CNV disorders.19,20 
Designed by the Kopelman group in collaboration with the laboratory of Dr. John Wolfe, the 
thiolated MIBG-derivative (‘dMIBG’) involves a 6-step synthesis. Following our protocol, the synthetic 
yield of the derived MIBG moiety is 100 mg – 200 mg, and the cost is at least 5x lower then the price of 
an equivalent molarity of the RGD peptide. Conjugated dMIBG-8-arm-PEG NPs have been successfully 
synthesized, with the dMIBG attachment confirmed via NMR spectroscopy. We are currently performing 
in vitro studies on the MIBG-PEG NP uptake, with plans to test MIBG-RGD-PEG NP uptakes in future 
experiments. Finally, in vivo experiments will proceed when the optimal in vitro ratios of MIBG and RGD 
peptide are determined, with ‘mono targeted’ MIBG and RGD PEG NPs used as controls, in addition to 
non-targeted controls. 
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